Coronary atherosclerosis

I9_CORATHER

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps	FinnGen
Phenotype data	557745
1. Apply sex-specific rule None	557745
2. Check conditions None	557745
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — I24, I25, T82.2, Z95.1 Hospital discharge: ICD-9 — 414\|9960A Hospital discharge: ICD-8 — 414 Hospital discharge: excluded ICD-10 — I25.3 Cause of death: ICD-10 — I24, I25, T82.2, Z95.1 Cause of death: ICD-9 — 414\|9960A Cause of death: ICD-8 — 414 Cause of death: excluded ICD-10 — I25.3 2 out of 7 registries used, show all original rules.	78396
4. Check minimum number of events None	78396
5. Include endpoints None	78396
6. Filter based on genotype QC (FinnGen only)	69390

Control definitions (FinnGen only)

Control exclude: I9_ISCHHEART

Extra metadata

Level in the ICD hierarchy: 3
First used in FinnGen datafreeze: DF2

NAME	I9_CORATHER
CONTROL_EXCLUDE	I9_ISCHHEART
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	I25\|I24\|Z951\|T822
HD_ICD_9	414\|9960A
HD_ICD_8	414
HD_ICD_10_EXCL	I253
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	I25\|I24\|Z951\|T822
COD_ICD_9	414\|9960A
COD_ICD_8	414
COD_ICD_10_EXCL	I253
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Coronary atherosclerosis based on the number of shared cases.

Similar with more cases:

Similar with less cases:

None

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	657584	279386	367876
Only index persons	436363	184909	251454
Unadjusted period prevalence (%)
Whole population	9.32	8.00	10.28
Only index persons	8.41	6.80	9.60
Median age at first event (years)
Whole population	72.88	77.44	69.41
Only index persons	71.32	76.17	67.74

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	69390	22353	47037
Unadjusted period prevalence (%)	17.18	7.94	21.57
Median age at first event (years)	69.00	70.56	68.26

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
35504: Matched controls
223793

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

138

Kela drug reimbursment

Severe anaemia associated with chronic renal failure

4.4

320.4

970

1425

R55

ICD-10 Finland

Syncope and collapse

2.0

316.4

3967

12974

I70.9

ICD-10 Finland

Generalized and unspecified atherosclerosis

6.0

316.0

688

737

I21.39

ICD-10 Finland

Acute transmural myocardial infarction with unspecified localization unspecified coronary artery status

789.5

315.2

372

A12BA01

ATC

potassium chloride; oral

3.1

314.7

1533

3177

Z03.5

ICD-10 Finland

Observation for other suspected cardiovascular diseases

2.3

314.5

2757

7790

FC1AC

NOMESCO Finland

Angiography of thoracal aortta

68.2

314.2

258

4120B

ICD-9 Finland

Old myocardial infarction[STATUS POST INFARCTUM CORDIS,AHTAUTUNUT]

+∞

311.6

360

E10.9

ICD-10 Finland

Type 1 diabetes mellitus, Without complications

3.2

308.0

1437

2898

A10AB01

ATC

insulin (human); parenteral

4.5

307.7

1384

2019

Z95.0

ICD-10 Finland

Presence of electronic cardiac devices

5.9

307.7

2232

2514

FNE20

NOMESCO Finland

Coronary bypass using free arterial graft of radial artery

+∞

307.7

438

GD1UA

NOMESCO Finland

Thorax X-ray examination outside radiological department

4.4

307.7

9635

17382

4130X

ICD-9 Finland

Angina pectoris, Angina decubitus[ANGINA PECTORIS (""""EFFORT ANGINA""""),MÄÄRITTELEMÄT]

+∞

307.7

573

AN3

Balloon angioplasty and metallic stent

+∞

307.7

2095

AN1

Coronary angiography

301.4

307.7

9807

283

K84

ICPC

Heart disease other

10.7

307.7

1772

1097

AA1AD

NOMESCO Finland

CT of head and brain

1.8

307.7

10973

44665

I24.9

ICD-10 Finland

Acute ischaemic heart disease, unspecified

174.0

307.7

274

C07AG02

ATC

carvedilol; oral

2.6

307.7

2260

5602

E11.5

ICD-10 Finland

Type 2 diabetes mellitus, with peripheral circulatory complications

5.0

307.7

874

1121

Z45.0

ICD-10 Finland

Adjustment and management of cardiac devices

5.5

307.7

1728

2048

FN1AC

NOMESCO Finland

Angiography of heart and/or coronary arteries

+∞

307.7

23932

E11.7

ICD-10 Finland

Type 2 diabetes mellitus, with multiple complications

5.0

307.7

2803

3769

WX720

NOMESCO Finland

Own respiration

2.9

307.7

1888

4267

215

Kela drug reimbursment

Diabetes, non-insulin-treated

2.3

307.7

10876

36661

TFC00

NOMESCO Finland

Catheterisation of right atrium or ventricle

38.9

307.7

624

103

XFP20

NOMESCO Finland

Check up of cardiac pacemaker

5.4

307.7

3016

3758

FPG30

NOMESCO Finland

Implantation of cardioverter-defibrillator with ventricular electrode

83.5

307.7

328

C09DX04

ATC

valsartan and sacubitril; oral

44.6

307.7

564

I49.5

ICD-10 Finland

Sick sinus syndrome

3.7

307.7

1401

2478

XF402

NOMESCO Finland

ECG with work load test

5.3

307.7

6242

8656

I46.0

ICD-10 Finland

Cardiac arrest with successful resuscitation

11.2

307.7

734

421

FN1BT

NOMESCO Finland

Extensive endovascular dilatation of coronary (PTCA) arteries

+∞

307.7

1771

I21.9

ICD-10 Finland

Acute myocardial infarction, unspecified

258.5

307.7

565

FPE20

NOMESCO Finland

Implantation of transvenous cardiac pacemaker with atrial and ventricular electrodes

3.8

307.7

1565

2664

SPAT1253

SPAT

Initiation, adjustment, discontinuation or repetition of medication

1.7

307.7

9387

39238

I21.40

ICD-10 Finland

Acute subendocardial infarction no detected stenosis of the coronary artery

2734.9

307.7

1681

K76

ICPC

Ischaemic heart dis without angina

69.8

307.7

2224

214

I42.0

ICD-10 Finland

Dilated cardiomyopathy

9.8

307.7

1132

749

I21.90

ICD-10 Finland

Myocardial infarction (acute) UNS no detected stenosis of the coronary artery

2735.4

307.7

860

Single vessel balloon catheter extension

+∞

307.7

1394

FN2AA

NOMESCO Finland

Percutaneous transluminal coronary angioplasty (PTCA), balloon only

+∞

307.7

673

B01AC06

ATC

acetylsalicylic acid; oral

53.2

307.7

1451

179

206

Kela drug reimbursment

Chronic coronary artery disease and dyslipidaemia associated with chronic coronary artery disease

285.4

307.7

20934

1121

C01DA14

ATC

isosorbide mononitrate; oral

39.8

307.7

14323

3735

TFP00

NOMESCO Finland

Temporary use of transvenous or epicardial pacemaker

15.2

307.7

465

195

XF404

NOMESCO Finland

Ambulatory ECG

3.3

307.7

3710

7599

205

Kela drug reimbursment

Chronic hypertension

2.3

307.7

11486

38740

I20.80

ICD-10 Finland

Other angina pectoris no detected stenosis of coronary artery

490.6

307.7

836

WX892

NOMESCO Finland

Monitored bed care

3.2

307.7

3298

6939

FN2CB

NOMESCO Finland

Percutaneous transluminal coronary angioplasty (PTCA) of coronary chronic total occlusion

+∞

307.7

606

N18.9

ICD-10 Finland

Chronic kidney disease, unspecified

2.9

307.7

2650

6078

FN1CC

NOMESCO Finland

Very extensive angiography of heart and/or coronary arteries

21.6

307.7

774

231

C01DA08

ATC

isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal

27.4

307.7

22979

14036

I20.89

ICD-10 Finland

Other angina pectoris unspecified coronary artery status

179.9

307.7

2837

108

N02AX02

ATC

tramadol; systemic, rectal

1.7

307.7

15852

72624

I35.0

ICD-10 Finland

Aortic (valve) stenosis

5.3

307.7

2754

3515

FN2AB

NOMESCO Finland

Percutaneous transluminal coronary angioplasty (PTCA), drug-eluting balloon

+∞

307.7

1835

Angiography of the heart and coronary arteries

62.8

307.7

4020

454

FM1AE

NOMESCO Finland

Standard cardiac ultrasound examination

5.3

307.7

10713

16985

I50

ICD-10 Finland

Heart failure

4.2

307.7

1178

1796

SPAT1250

SPAT

Comprehensive monitoring of chronic illness

1.9

307.7

10082

38981

FN1CB

NOMESCO Finland

Coronary flow reserve measurement with pressure wire

10568.1

307.7

3078

ZXD05

NOMESCO Finland

Urgent procedure

2.7

307.7

11801

35297

C10AA04

ATC

fluvastatin; oral

3.1

307.7

3968

8623

C10AX09

ATC

ezetimibe; oral

7.1

307.7

13560

17821

I21.19

ICD-10 Finland

Acute transmural myocardial infarction of inferior wall

+∞

307.7

976

FXA00

NOMESCO Finland

Total cardiopulmonary bypass in normothermia or moderate hypothermia at concurrent surgical procedure

76.1

307.7

2662

238

E78.9

ICD-10 Finland

Disorder of lipoprotein metabolism, unspecified

3.7

307.7

1599

2817

FN1BE

NOMESCO Finland

Ultrasound examination of coronary arteries through catheter

+∞

307.7

642

280

Kela drug reimbursment

Clopidogrel

566.6

307.7

962

Z95.1

ICD-10 Finland

Presence of aortocoronary bypass graft

4867.4

307.7

3518

SPAT1262

SPAT

Handing over of treatment supplies

2.0

307.7

6504

23063

FNC20

NOMESCO Finland

Aorto-coronary venous bypass with two distal anastomoses

+∞

307.7

1539

I21.41

ICD-10 Finland

Acute subendocardial infarction stenosed coronary artery

4503599627370496.0

307.7

4836

J44.8

ICD-10 Finland

Other specified chronic obstructive pulmonary disease

2.2

307.7

3800

11543

TFB00

NOMESCO Finland

Cathetrisation of pulmonal artery

34.0

307.7

970

185

C03CA01

ATC

furosemide; systemic

3.5

307.7

14998

38346

FME20

NOMESCO Finland

Transvenous aortic valve replacement via femoral artery

41.2

307.7

445

FNC10

NOMESCO Finland

Aorto-coronary venous bypass with single distal anastomosis

+∞

307.7

969

C01AA05

ATC

digoxin; systemic

3.2

307.7

2999

6198

289

Kela drug reimbursment

Combination product containing sacubitril and valsartan

45.2

307.7

593

TK800

NOMESCO Finland

Hemodialysis

4.8

307.7

985

1329

M04AA01

ATC

allopurinol; systemic

2.2

307.7

5123

16107

I21.10

ICD-10 Finland

Acute transmural myocardial infarction of inferior wall

+∞

307.7

543

I48

ICD-10 Finland

Atrial fibrillation and flutter

2.8

307.7

9347

25332

PD5AD

NOMESCO Finland

CT of aorta

5.4

307.7

1118

1340

PEF23

NOMESCO Finland

Thrombendarterectomy of femoral artery

6.5

307.7

775

763

FMD10

NOMESCO Finland

Replacement of aortic valve using biological prosthesis

74.3

307.7

591

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

1.8

307.7

10817

43609

C09AA02

ATC

enalapril; systemic

1.9

307.7

7378

27063

I11.9

ICD-10 Finland

Hypertensive heart disease without (congestive) heart failure

3.4

307.7

1777

3450

I20.81

ICD-10 Finland

Other angina pectoris stenosed coronary artery

9482.9

307.7

7247

FN2BA

NOMESCO Finland

Percutaneous transluminal coronary angioplasty with stent (includes balloon pre-dilation)

+∞

307.7

8025

Catheterization and pressure measurement of the left side of the heart

54.1

307.7

748

ZXD00

NOMESCO Finland

Emergency procedure

6.3

307.7

1317

1362

250, ,

Kela drug reimbursment

8.8

307.7

1050

768

AN4

Balloon angioplasty and drug eluding stent

+∞

307.7

3042

290

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation

2.6

307.7

7211

20259

I20.09

ICD-10 Finland

Unstable angina

347.0

307.7

4809

101

A10BK01

ATC

dapagliflozin; oral

2.5

307.7

3335

8998

I10

ICD-10 Finland

Essential (primary) hypertension

2.5

307.7

25887

116220

A10BH01

ATC

sitagliptin; oral

2.2

307.7

3764

11617

XPX99

NOMESCO Finland

Other diagnostic examination of periferal vessel

3.3

307.7

2866

5740

XFE00

NOMESCO Finland

Epicardial ultrasonography

5.7

307.7

928

1055

FN1YT

NOMESCO Finland

Percutaneous insertion of coronary artery stent

+∞

307.7

4923

I35.1

ICD-10 Finland

Aortic (valve) insufficiency

3.2

307.7

1929

3944

N08.39*E10.2

ICD-10 Finland

Insulin-dependent diabetes mellitus - Diabetic nephropathy

12.3

307.7

461

240

A10BK03

ATC

empagliflozin; oral

2.7

307.7

4698

12146

207

Kela drug reimbursment

Chronic arrhythmias

3.0

307.7

7244

17852

TFC10

NOMESCO Finland

Catheterisation of left atrium or ventricle

88.6

307.7

676

I70.2

ICD-10 Finland

Atherosclerosis of arteries of extremities

4.5

307.7

4747

7417

I21.97

ICD-10 Finland

Suspected acute myocardial infarction

65.9

307.7

505

E11.00

ICD-10 Finland

Non-insulin dependent diabetes diabetic hypoglycaemic coma

3.9

307.7

1249

2050

I21.00

ICD-10 Finland

Acute transmural myocardial infarction of anterior wall

4623.0

307.7

725

I20.0

ICD-10 Finland

Unstable angina

38.7

307.7

502

I21.49

ICD-10 Finland

Acute subendocardial infarction unspecified coronary artery status

1669.9

307.7

5007

TPH15

NOMESCO Finland

Insertion of central venous catheter through external or internal jugular vein

3.2

307.7

2717

5627

I21.09

ICD-10 Finland

Acute transmural myocardial infarction of anterior wall

2281.8

307.7

1073

I50.1

ICD-10 Finland

Left ventricular failure

12.6

307.7

2905

1575

I20.8

ICD-10 Finland

Other forms of angina pectoris

59.1

307.7

371

103

Kela drug reimbursment

Diabetes, insulin-treated

2.4

307.7

12155

39438

FN1BB

NOMESCO Finland

Contrast angiography of heart and/or coronary arteries after bypass surgery

+∞

307.7

675

FWD00

NOMESCO Finland

Reoperation for superficial haemorrhage in surgery of heart and major thoracic vessels

40.5

307.7

287

TPH04

NOMESCO Finland

Cathetrisation of vein

1.9

307.7

8190

30600

Z50.0

ICD-10 Finland

Cardiac rehabilitation

112.8

307.7

736

TFP20

NOMESCO Finland

Cardiodefibrillation

2.8

307.7

2783

6569

A10BA02

ATC

metformin; oral

2.1

307.7

11933

42711

Coronary artery bypass surgery

+∞

307.7

1075

I20.00

ICD-10 Finland

Unstable angina

1015.1

307.7

1977

C10AA03

ATC

pravastatin; oral

3.3

307.7

3412

6909

GD1PA

NOMESCO Finland

X-ray examination of the lungs in one projection

2.3

307.7

4175

12326

I25.8

ICD-10 Finland

Other forms of chronic ischaemic heart disease

422.8

307.7

915

GD1AA

NOMESCO Finland

Thorax X-ray examination

2.8

307.7

21168

76606

FN2CA

NOMESCO Finland

Percutaneous transluminal coronary angioplasty (PTCA), treating more than one main trunk during a single procedure

+∞

307.7

1166

A10AB05

ATC

insulin aspart; parenteral

3.2

307.7

3413

7229

C08DB01

ATC

diltiazem; oral

3.7

307.7

2109

3793

C09AA05

ATC

ramipril; oral

4.0

307.7

13725

30575

C07AB02

ATC

metoprolol; systemic

3.3

307.7

9210

21753

FN1BC

NOMESCO Finland

Extensive angiography of hear and/or coronary arteries

+∞

307.7

3720

I21.99

ICD-10 Finland

Myocardial infarction (acute) UNS unspecified coronary artery status

855.3

307.7

1557

E10.7

ICD-10 Finland

Type 1 diabetes mellitus, With multiple complications

6.4

307.7

1202

1224

R07.3

ICD-10 Finland

Other chest pain

3.0

307.7

4560

10380

C10AX13

ATC

evolocumab; parenteral

37.2

307.7

570

C03DA01

ATC

spironolactone; oral

3.7

307.7

6090

11783

XF400

NOMESCO Finland

ECG with 12 standard connections

2.6

307.7

6575

17800

I20.91

ICD-10 Finland

Angina pectoris, unspecified

1108.8

307.7

836

XF655

NOMESCO Finland

Measurement of heart muscle perfusion with exercise

15.2

307.7

1946

849

B01AC07

ATC

dipyridamole; systemic

3.4

307.7

1468

2837

FN1CA

NOMESCO Finland

Optical coherence tomography of coronary arteries

3681.7

307.7

581

R07.4

ICD-10 Finland

Chest pain, unspecified

4.9

307.7

15888

31628

TPH07

NOMESCO Finland

Cathetrisation of artery

3.1

307.7

5485

12317

I21.4

ICD-10 Finland

Acute subendocardial myocardial infarction

256.2

307.7

560

FN1XT

NOMESCO Finland

Other coronary artery procedure through catheter

+∞

307.7

392

I25.1

ICD-10 Finland

Atherosclerotic heart disease

1818.1

307.7

31297

912

I42.9

ICD-10 Finland

Cardiomyopathy, unspecified

8.8

307.7

574

418

AA1

Conventional CABG

+∞

307.7

1229

A10AB04

ATC

insulin lispro; parenteral

4.0

307.7

1187

1902

Z95.5

ICD-10 Finland

Presence of coronary angioplasty implant and graft

1155.5

307.7

3769

ZXE00

NOMESCO Finland

One hour or less

1.6

307.7

12522

56232

I25.2

ICD-10 Finland

Old myocardial infarction

1204.4

307.7

6419

T90

ICPC

Diabetes non-insulin dependent

2.1

307.7

10433

37469

J18.9

ICD-10 Finland

Pneumonia, unspecified

1.7

307.7

9129

37949

FN2CC

NOMESCO Finland

Percutaneous transluminal coronary angioplasty (PTCA) of left main trunk

+∞

307.7

595

B01AA03

ATC

warfarin; systemic

3.2

307.7

8270

19283

4100X

ICD-9 Finland

Acute myocardial infarction, Of anterolateral wall[INFARCTUS MYOCARDII ACUTUS DEFINITUS,MÄÄRITTELEMÄT]

+∞

307.7

669

PA6DE

NOMESCO Finland

Neck artery ultrasound examination with Doppler method

3.2

307.7

2024

4185

SPAT1097

SPAT

Recording of ECG

2.2

307.7

5472

17438

FN1AD

NOMESCO Finland

CT of coronary arteries

+∞

307.7

1066

R02

ICPC

Shortness of breath/dyspnoea

2.3

307.7

5179

15622

E11.8

ICD-10 Finland

Type 2 diabetes mellitus, with unspecified complications

3.0

307.7

5259

12112

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

2.1

307.7

7451

24966

4120X

ICD-9 Finland

Old myocardial infarction[STATUS POST INFARCTUM CORDIS,MÄÄRITTELEMÄT]

+∞

307.7

376

E78.00

ICD-10 Finland

Familial hypercholesterolaemia

3.9

307.7

1859

3164

I50.0

ICD-10 Finland

Congestive heart failure

6.1

307.7

3828

4366

I20.90

ICD-10 Finland

Angina pectoris, unspecified

307.1

307.7

2065

A10AA01, ,

ATC

4.6

307.7

1040

1460

A02BC02

ATC

pantoprazole; systemic

1.9

307.7

25082

125372

E78.5

ICD-10 Finland

Hyperlipidaemia, unspecified

3.5

307.7

5480

11176

C10AA05

ATC

atorvastatin; oral

4.5

307.7

23251

66574

K74

ICPC

Ischaemic heart dis with angina

41.9

307.7

945

146

B01AF02

ATC

apixaban; oral

2.1

307.7

5319

16987

I48.0

ICD-10 Finland

Paroxysmal atrial fibrillation

2.4

307.7

3599

9893

K77

ICPC

Heart failure

5.0

307.7

908

1175

C01DA02

ATC

glyceryl trinitrate; oral, oral aerosol, sublingual, transdermal

10.2

307.7

12778

11647

A10BB12

ATC

glimepiride; oral

2.8

307.7

2640

6282

B01AC04

ATC

clopidogrel; oral

13.3

307.7

14417

10905

C07AB07

ATC

bisoprolol; oral

6.5

307.7

26477

69313

4130B

ICD-9 Finland

Angina pectoris, Angina decubitus[ANGINA PECTORIS (""""EFFORT ANGINA""""),AHTAUTUNUT]

+∞

307.7

587

FL1AC

NOMESCO Finland

Left cardioangiography

624.6

307.7

964

FXZ00

NOMESCO Finland

Off-pump cardiac operation

201.4

307.7

348

I21.01

ICD-10 Finland

Acute transmural myocardial infarction of anterior wall

+∞

307.7

1530

FNC30

NOMESCO Finland

Aorto-coronary venous bypass with three distal anastomoses

+∞

307.7

1090

C08CA07

ATC

nisoldipine; oral

14.9

307.7

450

193

A10AA02, ,

ATC

4.6

307.7

1357

1899

C08CA01

ATC

amlodipine; oral

2.1

307.7

16486

65409

I20

ICD-10 Finland

Angina pectoris

18.9

307.7

856

292

AN2

Balloon angioplasty, including several vessels

+∞

307.7

1697

C10AA01

ATC

simvastatin; oral

3.5

307.7

20748

64778

FNC40

NOMESCO Finland

Aorto-coronary venous bypass with four distal anastomoses

+∞

307.7

426

AP1

Catheterization of the left side of the heart

135.4

307.7

880

FM1EE

NOMESCO Finland

Extensive structural and functional ultrasound examination of heart

5.4

307.7

13906

23756

Z95.2

ICD-10 Finland

Presence of prosthetic heart valve

24.2

307.7

1039

279

ZXE20

NOMESCO Finland

More than three and less than five hours

2.1

307.7

4763

15427

C10AA07

ATC

rosuvastatin; oral

2.3

307.7

15186

54983

I34.09

ICD-10 Finland

Mitral (valve) insufficiency

4.1

307.7

1599

2560

E11.9

ICD-10 Finland

Type 2 diabetes mellitus, without complications

2.4

307.7

10880

35222

FNA01

NOMESCO Finland

Anastomosis to coronary artery from internal mammary artery, one distal anastamosis

+∞

307.7

3997

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

1.9

307.7

5793

20823

213

Kela drug reimbursment

Fat metabolism disorder associated with chronic coronary artery disease

113.6

307.7

5181

336

B01AC24

ATC

ticagrelor; oral

954.5

307.7

4497

K78

ICPC

Atrial fibrillation/flutter

2.5

307.7

2857

7708

I21.21

ICD-10 Finland

Acute transmural myocardial infarction with another location stenosed coronary artery

+∞

307.7

390

201

Kela drug reimbursment

Chronic cardiac insufficiency

9.2

307.7

3116

2309

I20.99

ICD-10 Finland

Angina pectoris, unspecified

190.3

307.7

5097

197

FM1CR

NOMESCO Finland

Heart perfusion PET with TT

141.3

307.7

267

I20.9

ICD-10 Finland

Angina pectoris, unspecified

24.4

307.7

695

183

FM1DE

NOMESCO Finland

Doppler ultrasound examination of heart

3.7

307.7

4364

8197

R07.2

ICD-10 Finland

Precordial pain

5.8

307.7

978

1095

A10AC01

ATC

insulin (human); parenteral

3.7

307.7

3176

5839

381

Kela drug reimbursment

Combination product containing sacubitril and valsartan

44.7

307.7

538

A10AE05

ATC

insulin detemir; parenteral

3.4

307.7

2209

4287

R06.0

ICD-10 Finland

Dyspnoea

2.9

307.7

12076

33434

FPG32

NOMESCO Finland

Implantation of cardioverter-defibrillator with atrial and ventricular electrodes

27.2

307.7

334

FM1BE

NOMESCO Finland

Cardiac ultrasound examination through oesophagus

6.6

307.7

3509

3641

WX872

NOMESCO Finland

Intensive care

8.0

307.7

3094

2652

294

Kela drug reimbursment

Alirocumab and evolocumab for the treatment of hypercholesterolaemia and dyslipidaemia

256.4

307.7

600

I35.2

ICD-10 Finland

Aortic (valve) stenosis with insufficiency

5.3

307.7

972

1179

3015

Kela drug reimbursment

Alirocumab and evolocumab for the treatment of hypercholesterolaemia and dyslipidaemia

47.3

307.7

648

I25.9

ICD-10 Finland

Chronic ischaemic heart disease, unspecified

225.6

307.7

9523

363

I34.00

ICD-10 Finland

Mitral (valve) incompetence NOS or of specified cause, except rheumatic

6.3

307.7

722

735

I25

ICD-10 Finland

Chronic ischaemic heart disease

97.0

307.7

4520

336

25000

ICD-8 Finland

Diabetes mellitus, Sine complicatione

4.4

307.7

1086

1606

B01AC22

ATC

prasugrel; oral

90.2

307.7

326

351

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation

2.5

307.7

6441

18228

A10AE04

ATC

insulin glargine; parenteral

3.0

307.7

4433

10282

K01

ICPC

Heart pain

7.6

307.7

636

537

I47.2

ICD-10 Finland

Ventricular tachycardia

9.6

307.7

936

630

E78.01

ICD-10 Finland

Pure hypercholesterolaemia

2.3

307.7

11700

39684

I21.11

ICD-10 Finland

Acute transmural myocardial infarction of inferior wall

+∞

307.7

1358

FN1AT

NOMESCO Finland

Endovascular dilatation of coronary arteries (PTCA)

+∞

307.7

3999

I25.5

ICD-10 Finland

Ischaemic cardiomyopathy

725.8

307.7

1223

I50.9

ICD-10 Finland

Heart failure, unspecified

5.2

307.7

7605

11146

ANC

Coronary artery pressure measurement (FFR, fractional flow reserve)

29.2

307.7

485

106

A11

ICPC

Chest pain NOS

3.5

307.7

4186

8183

C10AA02

ATC

lovastatin; oral

3.4

307.7

1482

2850

I25.0

ICD-10 Finland

Atherosclerotic cardiovascular disease, so described

216.8

307.7

5718

198

I20.01

ICD-10 Finland

Unstable angina

2975.4

307.7

2664

C01BD01

ATC

amiodarone; systemic

6.8

307.7

1339

1281

H3603, E103,

ICD-10 Finland

8.7

307.2

494

361

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

1.9

307.1

5076

18268

XFN00

NOMESCO Finland

Inside imaging of coronary arteries??

64.2

305.9

253

B04AB02, ,

ATC

6.0

304.8

665

714

111

Conventional CABG

+∞

304.6

352

CJE20

NOMESCO Finland

Phakoemulsification with implantation of artificial lens in posterior chamber

1.6

302.9

11520

52120

FB1BD

NOMESCO Finland

Extensive CT examination of arteria pulmonalis

2.3

301.3

2747

7892

R4110

NOMESCO Finland

Physiotherapy

1.6

297.2

9675

42123

I48.9

ICD-10 Finland

Atrial fibrillation and atrial flutter, unspecified

2.2

296.9

2973

8888

R03BB04

ATC

tiotropium bromide; inhalant

2.0

294.3

3638

11816

R03AC02

ATC

salbutamol; inhalant

1.5

294.2

17466

87071

123

Kela drug reimbursment

Chronic disorders of vitamin D metabolism

4.2

293.6

939

1443

K92

ICPC

Atherosclerosis/periph vascular dis

5.9

293.6

650

709

I49.0

ICD-10 Finland

Ventricular fibrillation and flutter

12.8

292.5

375

186

K02

ICPC

Pressure/tightness of heart

4.2

291.2

932

1433

I44.2

ICD-10 Finland

Atrioventricular block, complete

4.1

289.9

954

1500

5315

FHL

Bypass surgery using a mammary artery

+∞

289.9

335

A10BB01

ATC

glibenclamide; oral

3.2

288.7

1329

2656

C08CA13

ATC

lercanidipine; oral

1.8

288.5

5514

20737

C08CA02

ATC

felodipine; oral

2.1

288.4

3532

11428

FMD00

NOMESCO Finland

Replacement of aortic valve using mechanical prosthesis

20.6

288.4

304

I48.2

ICD-10 Finland

Chronic atrial fibrillation

2.8

287.7

1691

3910

WW502

NOMESCO Finland

Autotransfusion

16.0

286.5

332

132

E11

ICD-10 Finland

Type 2 diabetes mellitus

1.8

282.2

5907

22809

D64.9

ICD-10 Finland

Anaemia, unspecified

2.0

279.4

3963

13514

T89

ICPC

Diabetes insulin dependent

3.0

278.3

1436

3079

PD5BD

NOMESCO Finland

Extensive CT of aorta

5.3

274.5

675

820

WX105

NOMESCO Finland

Surface analgesia on skin or mucosa

2.1

274.1

3258

10413

GD1LA

NOMESCO Finland

6.7

271.2

533

508

I65.2

ICD-10 Finland

Occlusion and stenosis of carotid artery

4.4

270.3

816

1195

C08CA05

ATC

nifedipine; systemic

2.5

269.8

2050

5409

PD4DE

NOMESCO Finland

Lower extremity artery ultrasound examination with Doppler method

4.3

266.1

822

1227

I63.9

ICD-10 Finland

Cerebral infarction, unspecified

2.0

264.4

3642

12277

H25.1

ICD-10 Finland

Senile nuclear cataract

1.6

263.9

9753

43522

R42

ICD-10 Finland

Dizziness and giddiness

1.6

263.4

7849

33259

I21.29

ICD-10 Finland

Acute transmural myocardial infarction with other localization unspecified coronary artery status

1912.2

263.2

307

H02AB06

ATC

prednisolone; systemic

1.5

262.4

15928

79052

Z49.1

ICD-10 Finland

Extracorporeal dialysis

5.5

258.5

613

718

AB2

AVR bio, stent

125.5

254.2

198

5253

FHL

Cardiac lung machine

23.1

254.0

258

PE1AT

NOMESCO Finland

Femoral artery PTA

5.9

251.7

557

607

Z95.3

ICD-10 Finland

Presence of xenogenic heart valve

47.5

251.5

217

C02AC05

ATC

moxonidine; oral

2.5

250.8

1798

4608

SPAT1263

SPAT

Sampling

1.5

250.5

12829

61305

N18.8

ICD-10 Finland

Other chronic renal failure

3.7

249.1

941

1642

E10.2

ICD-10 Finland

Type 1 diabetes mellitus, With renal complications

7.7

248.5

435

358

H36.03

ICD-10 Finland

Proliferative diabetic retinopathy

8.3

247.3

410

313

E10.3

ICD-10 Finland

Type 1 diabetes mellitus, With ophthalmic complications

3.8

246.7

894

1513

Z3231

NOMESCO Finland

Registered nurse

1.6

246.4

8712

38366

ZXE30

NOMESCO Finland

More than five and less than seven hours

2.6

246.3

1654

4100

PD4BC

NOMESCO Finland

Extensive arterigography of lower extremity with X-ray

4.7

246.1

677

914

C09CA01

ATC

losartan; oral

1.6

244.5

9327

41779

N17.9

ICD-10 Finland

Acute renal failure, unspecified

2.6

244.1

1602

3924

4140B

ICD-9 Finland

Other forms of chronic ischaemic heart disease, Coronary atherosclerosis[ATHEROSCLEROSIS ARTER CORON CORDIS,AHTAUTUNUT]

+∞

243.9

282

C03AA03

ATC

hydrochlorothiazide; oral

2.0

243.6

3217

10667

A02BC01

ATC

omeprazole; systemic

1.6

241.4

8834

39177

FM1DG

NOMESCO Finland

Very extensive MRI examination of heart with high intesity magnet

7.2

240.8

447

397

SPAT1249

SPAT

Treatment-related counselling outside office

1.5

238.8

11835

56024

285

Kela drug reimbursment

Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)

2.2

237.8

2284

6687

R53

ICD-10 Finland

Malaise and fatigue

1.6

236.9

7675

33061

A10BH05

ATC

linagliptin; oral

2.4

235.7

1877

5056

M10.9

ICD-10 Finland

Gout, unspecified

2.1

233.5

2541

7827

AA2

Off pump CABG sternotomy

+∞

233.5

270

L97

ICD-10 Finland

Ulcer of lower limb, not elsewhere classified

2.7

233.3

1504

3649

PD4AC

NOMESCO Finland

Arterigography of lower extremity with X-ray

5.0

232.6

604

773

J45.9

ICD-10 Finland

Asthma, unspecified

1.7

232.3

6011

24466

Multi-vessel balloon catheter extension

+∞

231.8

268

D50.9

ICD-10 Finland

Iron deficiency anaemia, unspecified

2.1

231.8

2738

8706

SPAT1301

SPAT

No procedures

1.5

230.6

9798

44827

SPAT1148

SPAT

Treatment of chronic ulcer or burn

1.8

230.0

4499

16938

E11.2

ICD-10 Finland

Type 2 diabetes mellitus, with renal complications

2.9

229.7

1271

2835

TFN04, ,

NOMESCO Finland

53.5

229.0

194

PH1AC

NOMESCO Finland

Flebography of over extremity with X-ray

6.5

228.6

462

455

FN2EA

NOMESCO Finland

Coronary rotablation

+∞

228.3

264

ZXD10

NOMESCO Finland

Scheduled procedure

1.5

227.9

12063

57728

PD4CG

NOMESCO Finland

Extensive MRI examination of abdominal aortta and vasculature of lower extremities with high intensity magnet

5.2

227.6

571

707

Z01.8

ICD-10 Finland

Other specified special examinations

1.6

226.8

7384

31794

N02BE01

ATC

paracetamol; systemic, rectal

1.7

226.7

30823

177985

C07AB03

ATC

atenolol; systemic

2.3

225.8

1932

5376

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

1.8

225.3

4503

17051

A02BC03

ATC

lansoprazole; oral

1.5

225.3

9455

43099

UJF32

NOMESCO Finland

Coloscopy

1.5

223.8

8967

40454

R00.1

ICD-10 Finland

Bradycardia, unspecified

3.0

223.8

1180

2559

N08.39*E11.2

ICD-10 Finland

Non-insulin-dependent diabetes mellitus - Diabetic nephropathy

4.4

223.7

670

974

I49.3

ICD-10 Finland

Ventricular premature depolarization

2.1

222.7

2387

7305

XF600

NOMESCO Finland

Bloodpressure measurement

2.2

222.3

2117

6171

PEN23

NOMESCO Finland

Plastic repair of femoral artery

6.7

221.9

433

409

C03EB01

ATC

furosemide and potassium-sparing agents; systemic

2.8

221.7

1282

2931

190

Kela drug reimbursment

Lanthanum carbonate, sevelamer and sucroferric oxyhydroxide

6.8

220.8

428

401

N02AJ06

ATC

codeine and paracetamol; systemic

1.5

220.1

14082

69789

J44.9

ICD-10 Finland

Chronic obstructive pulmonary disease, unspecified

2.5

219.9

1589

4083

NHQ40

NOMESCO Finland

Amputation of toe

4.2

219.1

695

1060

C07AA07

ATC

sotalol; systemic

2.9

218.8

1183

2603

PD3YT

NOMESCO Finland

Pelvic artery PTA with stent

5.2

218.0

546

675

K83

ICPC

Heart valve disease NOS

9.3

217.3

334

228

N03AX16

ATC

[U] pregabalin

1.6

217.1

7649

33495

FP1C5

NOMESCO Finland

Resting ECG, 15 leads

5.6

216.3

495

559

E11.6

ICD-10 Finland

Type 2 diabetes mellitus, with other specified complications

3.8

216.2

782

1321

QDB10

NOMESCO Finland

Major dressing of wound of skin of lower limb

2.4

215.8

1796

4933

4019X

ICD-9 Finland

Essential hypertension, Unspecified

3.5

215.2

882

1629

T81.0

ICD-10 Finland

Haemorrhage and haematoma complicating a procedure, not elsewhere classified

2.2

214.9

2051

5982

346

Kela drug reimbursment

Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)

2.2

214.5

2115

6253

A10AE06

ATC

insulin degludec; parenteral

2.8

214.0

1281

2985

G47.3

ICD-10 Finland

Sleep apnoea

1.5

213.5

8029

35658

A11CC03

ATC

alfacalcidol; systemic

3.4

212.5

889

1665

FN2DB

NOMESCO Finland

Percutaneous transluminal coronary angioplasty (PTCA) of coronary restenosis

+∞

211.9

245

XCK10

NOMESCO Finland

Photography of fundus of eye

1.9

211.2

3290

11518

A10AD01

ATC

insulin (human); parenteral

4.7

210.4

578

779

4111X

ICD-9 Finland

Other acute and subacute forms of ischaemic heart disease, Intermediate coronary syndrome[PITKITTYNYT ANGINA PECTORIS -KOHTAUS,MÄÄRITTELEMÄT]

+∞

210.1

243

2500A

ICD-9 Finland

Diabetes mellitus without mention of complication[DIABETES MELLITUS SINE COMPLICATIONE,TYYPPI II]

4.2

210.1

674

1037

I20.10

ICD-10 Finland

Angina angiospastic

783.6

209.2

247

C03EA01

ATC

hydrochlorothiazide and potassium-sparing agents; oral

1.7

206.8

5074

20302

I21

ICD-10 Finland

Acute myocardial infarction

60.5

206.4

172

E11.3

ICD-10 Finland

Type 2 diabetes mellitus, with ophthalmic complications

2.9

205.8

1107

2428

A02BA02

ATC

ranitidine; systemic

1.6

203.4

6246

26433

C09CA03

ATC

valsartan; oral

1.8

202.1

3351

11961

FM1TQ

NOMESCO Finland

Heart perfusion SPECT with low dose CT at rest and with exercise

17.0

202.0

228

1CX08, ,

NOMESCO Finland

40.5

201.9

179

K29

ICPC

Cardiovascular sympt/complt other

2.4

200.9

1615

4363

R04.0

ICD-10 Finland

Epistaxis

2.0

199.5

2540

8287

127

Kela drug reimbursment

Transplant complication

4.2

198.9

627

951

FN1CD

NOMESCO Finland

Very extensive CT of coronary arteries

7.2

198.7

369

328

FPE00

NOMESCO Finland

Implantation of transvenous cardiac pacemaker with ventricular electrode

4.1

198.1

637

982

H3603, E113,

ICD-10 Finland

6.6

197.8

391

375

XF640, ,

NOMESCO Finland

3.2

197.5

908

1809

WX870

NOMESCO Finland

LabWAS

↥

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count

15078

71872

1.56

321.57

4.3

3.4

2.54

1.59

e6/l

0.27

(3004119) Hemoglobin [Mass/volume] in Venous blood

3626

11445

2.11

317.47

4.5

2.7

124.17

130.95

g/l

49.54

3511

11165

(3018418) pH of Serum or Plasma

13156

61202

1.56

308.14

5.7

4.2

7.40

10.07

9853

43043

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

6362

21749

2.03

307.65

2.1

1.8

—

(3027801) Oxygen [Partial pressure] in Arterial blood

7623

21186

2.61

307.65

9.6

7.1

11.96

12.61

kpa

19.19

7372

20435

(3013512) EKG study

14921

70415

1.58

307.65

5.1

3.2

0.75

0.74

0.06

156

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

18982

52279

3.77

307.65

4.2

2.4

1809.75

1012.11

ng/l

64.68

17250

43401

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

2449

5500

2.94

307.65

3.8

2.5

0.33

0.37

iu/ml

4.37

1479

2766

(3021447) Carbon dioxide [Partial pressure] in Venous blood

5793

18707

2.14

307.65

5.2

3.4

5.82

5.80

kpa

0.77

5651

18291

(3023520) Reticulocytes [#/volume] in Blood

5093

17502

1.97

307.65

2.6

72.21

68.15

e9/l

11.25

3814

12692

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

6703

23544

1.98

307.65

2.0

1.8

—

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

19563

69801

2.71

307.65

5.9

2.9

135.20

30.53

ng/l

4.40

15493

49766

(3012095) Magnesium [Moles/volume] in Serum or Plasma

8690

32805

1.89

307.65

4.1

3.3

0.81

mmol/l

0.72

8225

30722

(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood

4407

12012

2.50

307.65

12.0

9.0

1.34

1.31

0.76

4384

11944

(3020779) Urea [Moles/volume] in Serum or Plasma

5744

16258

2.46

307.65

11.5

6.0

11.29

9.60

mmol/l

46.56

5535

15509

(3014007) Fractional oxyhemoglobin in Arterial blood

4435

12081

2.50

307.65

12.1

9.0

93.88

93.98

0.46

4418

12052

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

19198

91707

1.70

307.65

9.9

6.1

1.20

1.22

mmol/l

195.60

18052

84239

(3016502) Oxygen saturation in Arterial blood

6993

18539

2.72

307.65

9.9

7.5

95.54

95.67

0.84

6781

17978

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

8595

31924

1.92

307.65

2.1

1.9

—

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

12269

47375

1.97

307.65

2.8

2.2

2.97

2.80

mg/l

9.77

10869

40164

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

5712

12092

3.36

307.65

3.7

2.2

253.07

139.74

ng/l

42.50

5341

10878

(3012544) pH of Venous blood

6023

18830

2.22

307.65

5.3

3.4

7.37

7.38

7.70

3584

10497

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

7626

21197

2.61

307.65

9.7

7.1

5.05

5.14

kpa

12.84

7378

20450

(3024561) Albumin [Mass/volume] in Serum or Plasma

18876

91255

1.65

307.65

6.3

5.0

34.89

35.51

g/l

38.94

17785

85176

(3001122) Ferritin [Mass/volume] in Serum or Plasma

16778

80990

1.58

307.65

4.0

2.8

149.73

154.33

ug/l

0.94

15611

74583

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

3815

11627

2.20

307.65

12.3

8.6

24.11

24.36

mmol/l

4.33

3727

11398

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

3504

10812

2.16

307.65

5.4

3.6

24.00

24.37

mmol/l

8.66

3456

10671

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

13633

62691

1.60

307.65

3.3

2.7

59.34

66.00

u/l

2.50

12773

57617

(3002173) Hemoglobin [Mass/volume] in Arterial blood

6539

17447

2.67

307.65

10.5

7.9

119.89

121.78

g/l

9.37

6417

17072

(3006217) Methemoglobin/Hemoglobin.total in Arterial blood

4292

11629

2.51

307.65

12.3

9.2

0.64

0.62

1.34

4269

11574

(3024354) Oxygen [Partial pressure] in Venous blood

4768

15532

2.08

307.65

4.2

2.8

4.62

4.53

kpa

1.72

4636

15147

(3018677) aPTT in Platelet poor plasma by Coagulation assay

9209

26755

2.58

307.65

2.6

1.9

30.49

29.16

53.36

9018

26017

(3023368) Bacteria identified in Blood by Culture

13298

55069

1.83

307.65

5.3

4.2

—

(3004789) Transferrin [Mass/volume] in Serum or Plasma

8874

29020

2.24

307.65

3.6

2.3

2.31

2.29

g/l

2.68

8311

26527

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

21740

104419

1.81

307.65

7.0

12.11

11.64

umol/l

5.65

20889

99361

(3020682) Albumin/Creatinine [Ratio] in Urine

16636

68993

1.98

307.65

4.8

4.1

12.90

6.86

mg/mmol

28.71

10977

41562

(3022948) Iron [Moles/volume] in Serum or Plasma

9327

31135

2.20

307.65

3.6

2.4

11.82

13.81

umol/l

2.54

8778

28761

(3018405) Lactate [Moles/volume] in Arterial blood

2251

5121

2.89

307.65

4.8

3.9

1.38

1.40

mmol/l

0.23

2207

5030

(3013826) Glucose [Moles/volume] in Serum or Plasma

24906

114134

2.26

307.65

7.8

4.5

7.15

6.72

mmol/l

140.24

24146

108528

(3032080) INR in Blood by Coagulation assay

22888

89479

2.72

307.65

21.2

11.5

1.33

1.21

inr

177.99

19821

72843

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

20771

102416

1.67

307.65

10.9

6.7

1.20

1.22

mmol/l

209.63

18205

87631

(3019977) pH of Arterial blood

7638

21199

2.62

307.65

9.6

7.1

7.42

0.06

4311

10910

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

15944

59880

2.23

307.65

2.7

2.1

219.80

212.51

u/l

0.37

15099

56437

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

7002

11473

4.55

307.65

2.9

1.8

10.38

3.95

ug/l

58.13

6378

9558

(3008152) Bicarbonate [Moles/volume] in Arterial blood

4305

10311

2.86

307.65

8.3

6.3

24.43

24.73

mmol/l

4.94

4160

9873

(3002032) Base excess in Venous blood by calculation

5682

18265

2.14

307.65

5.3

3.4

1.62

1.89

mmol/l

5.85

5054

16143

(3014111) Lactate [Moles/volume] in Serum or Plasma

5343

17619

2.07

307.65

10.4

6.8

1.37

1.33

mmol/l

1.75

5249

17283

(3043409) Potassium [Moles/volume] in Arterial blood

1947

4236

3.01

307.65

5.1

4.2

3.93

3.83

mmol/l

12.54

1931

4208

(3044889) 12 lead EKG panel

26214

136535

1.80

307.65

6.5

3.5

7760.09

2443.01

0.38

268

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

11743

34492

2.71

307.65

6.3

2.8

1061.20

68.02

ng/l

29.57

10552

26692

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

3899

10646

2.47

307.65

12.8

8.5

15.82

16.15

9.51

3796

10298

(3009508) Creatinine [Moles/volume] in Urine

16589

70097

1.92

307.65

4.0

3.4

7.16

7.64

mmol/l

38.17

14118

58462

(3020891) Body temperature

3060

7973

2.55

307.65

5.6

4.2

36.89

36.91

°c

1.94

3026

7909

(3000991) Gas panel - Venous blood

5166

16617

2.12

307.65

12.3

8.0

—

(3027945) Reticulocytes/Erythrocytes in Blood

6356

22382

1.96

307.65

2.6

2.5

1.88

1.76

17.00

5723

19792

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

18057

89061

1.57

307.65

3.3

2.7

—

estimate

—

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

8357

26745

2.27

307.65

3.6

2.4

20.64

23.18

54.48

7858

24589

(3012516) Albumin [Mass/volume] in Urine

16412

67742

1.98

307.65

4.0

3.4

65.08

40.11

mg/l

22.96

11274

41609

(3016293) Bicarbonate [Moles/volume] in Serum or Plasma

3909

12514

2.09

307.65

11.1

6.9

24.55

24.94

mmol/l

8.48

3886

12418

(3003396) Base excess in Arterial blood by calculation

7582

21085

2.61

307.65

9.5

7.0

0.87

0.96

mmol/l

0.96

6344

17682

(3003458) Phosphate [Moles/volume] in Serum or Plasma

7009

25872

1.88

307.65

9.3

5.2

1.08

1.01

mmol/l

63.35

6652

23958

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

10174

38448

1.94

307.65

2.2

1.6

1.28

1.36

mg/l

1.35

8036

30289

(3004451) EKG impression Narrative

616

622

6.34

298.31

1.4

1.1

—

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

6044

23203

1.77

296.04

4.5

4.8

250.32

240.11

u/l

4.34

5738

21966

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

2771

8066

2.26

294.60

6.2

4.4

1.70

1.61

3.06

2645

7681

(3000850) Epithelial cells [#/volume] in Urine

10023

44172

1.60

291.85

3.4

2.6

4.94

5.15

e6/l

0.89

9214

40134

(3007930) Methemoglobin/Hemoglobin.total in Blood

2573

7339

2.30

286.34

6.5

4.6

0.88

0.87

0.36

2450

6967

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

27614

152789

1.63

285.52

10.0

8.5

81.65

80.41

u/l

3.49

26490

144473

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

2856

8601

2.19

279.48

1.7

1.62

1.60

g/l

0.49

2499

7359

(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood

3118

9742

2.12

278.36

3.8

2.6

1.27

1.25

0.34

3108

9702

(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood

337

150

14.29

276.85

8.3

8.9

6.05

5.82

kpa

1.98

307

133

(3002582) Erythrocytes [#/volume] in Urine

13716

65742

1.51

269.78

4.2

3.3

78.98

74.49

e6/l

0.13

10915

49361

(4094501) Cardiovascular stress test using bicycle ergometer

1930

4993

2.52

264.38

1.2

1.1

—

(3024889) Methemoglobin/Hemoglobin.total in Venous blood

3065

9714

2.08

263.07

3.7

2.6

0.62

0.26

3058

9687

(3026493) Urate [Moles/volume] in Serum or Plasma

11497

53299

1.53

262.01

3.4

2.6

363.92

343.95

umol/l

68.34

10103

46742

(3031040) Bacteria [#/volume] in Urine by Automated count

23426

125895

1.51

259.27

6.0

4.6

2004.57

1753.25

e6/l

0.19

354

1812

(3047181) Lactate [Moles/volume] in Blood

1949

5123

2.48

258.26

7.0

5.2

1.37

1.32

mmol/l

1.27

1757

4529

(3038071) Oxygen [Partial pressure] in Mixed venous blood

307

132

14.78

256.17

8.2

9.2

5.50

6.51

kpa

2.82

307

132

(3013115) Eosinophils [#/volume] in Blood

19557

101485

1.48

254.97

7.2

6.6

0.21

0.19

e9/l

17.68

17146

87085

(3006315) Basophils [#/volume] in Blood

19094

98629

1.48

254.55

7.0

6.4

0.04

e9/l

5.44

16429

83321

(3001604) Monocytes [#/volume] in Blood

19033

98317

1.47

253.00

6.9

6.4

0.64

0.59

e9/l

87.23

16374

83070

(3027456) Digoxin [Moles/volume] in Serum or Plasma

1358

2993

2.93

250.86

3.2

3.3

0.84

0.78

nmol/l

4.90

1080

2372

(3019198) Lymphocytes [#/volume] in Blood

19352

100394

1.47

250.66

7.0

6.4

1.87

1.91

e9/l

1.93

17047

86928

(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood

2882

9085

2.09

250.32

5.0

3.6

48.87

47.31

2.52

2841

8969

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

13299

64086

1.49

248.84

3.6

3.3

38.82

34.21

u/l

3.14

12521

60174

(3013650) Neutrophils [#/volume] in Blood by Automated count

20930

110905

1.46

236.49

9.5

10.4

4.50

4.10

e9/l

87.66

18231

95012

(3030467) Casts [#/volume] in Urine by Automated count

11959

56854

1.49

235.45

4.1

3.2

0.51

0.42

e6/l

2.93

9195

40853

(3021960) Folate [Moles/volume] in Serum or Plasma

12112

57844

1.49

232.38

1.8

1.7

19.44

20.55

nmol/l

12.78

10479

48138

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

2339

6989

2.19

231.76

2.9

2.0

638.63

527.16

ug/l

0.58

2255

6597

(3019309) Folate [Moles/volume] in Red Blood Cells

7743

33653

1.58

228.90

1.9

1.7

1211.38

1132.07

nmol/l

10.40

6028

24942

(3018572) Chloride [Moles/volume] in Blood

1430

3415

2.71

228.44

7.9

6.3

104.95

104.82

mmol/l

0.39

1311

3088

(3039000) Anion gap in Blood by calculation

1430

3415

2.71

228.44

7.9

6.3

11.44

11.20

mmol/l

1.59

1309

3088

(3018095) Leukocytes [#/volume] in Urine

14848

74022

1.45

227.39

4.9

4.0

101.96

100.12

e6/l

0.08

11150

51551

(3034037) Hematocrit [Volume Fraction] of Mixed venous blood by calculation

246

17.54

220.47

7.4

4.7

10.45

10.84

0.65

246

(3027273) Bicarbonate [Moles/volume] in Venous blood

2581

8205

2.06

218.10

4.6

3.0

25.13

25.35

mmol/l

2.40

2494

7965

(36304419) Bacteria [Presence] in Urine

11263

53684

1.47

213.56

4.0

3.2

311.58

4.66

estimate

0.51

229

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

17646

91540

1.43

212.78

2.4

2.1

95.01

96.23

pmol/l

2.57

9613

47719

(3042936) Bacteria identified in Isolate by Culture

6650

28304

1.59

212.58

2.5

2.0

—

(3007853) Bacteria identified in Skin by Aerobe culture

5521

22476

1.65

210.99

2.2

1.7

—

(3028626) Oxygen [Partial pressure] in Capillary blood

1573

4126

2.47

208.47

3.6

2.7

7.99

8.09

kpa

1.56

1548

4015

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

2451

7786

2.06

207.15

2.1

1.9

1.85

2.34

ug/l

1.38

2216

6862

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

3560

12860

1.83

206.99

4.5

3.3

5.11

5.16

kpa

3.30

3424

12173

(46236952) Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)/1.73 sq M

4022

15207

1.75

200.59

3.3

2.7

58.35

67.31

ml/min/173m2

37.87

1921

6053

(3015235) Bicarbonate [Moles/volume] in Capillary blood

2150

6578

2.13

200.04

3.6

2.6

24.54

24.85

mmol/l

2.82

2117

6456

(3009343) pH of Capillary blood

3448

12489

1.82

198.27

4.5

3.3

7.41

7.42

4.08

2971

10230

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

3063

10768

1.87

193.26

4.2

3.2

1.87

1.81

mmol/l

0.42

2229

8089

(3021901) Oxygen saturation in Capillary blood

1404

3622

2.50

192.34

3.6

2.8

89.62

90.10

1.65

1379

3511

(3035350) Ketones [Presence] in Urine by Test strip

19404

103400

1.40

192.05

5.0

3.8

4.14

4.35

estimate

0.06

4258

20632

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

1520

4117

2.39

187.83

2.8

2.2

148.32

89.73

ug/min

4.00

956

2375

(40767503) Oxygen content in Capillary blood by calculation

1374

3585

2.47

183.76

3.2

2.5

16.17

16.48

2.65

1356

3500

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

3764

14325

1.73

182.34

1.8

1.6

—

(3009261) Glucose [Presence] in Urine by Test strip

19481

104386

1.39

181.94

5.0

3.8

0.03

0.36

estimate

2.08

3840

19570

(3021601) Nitrite [Presence] in Urine by Test strip

19131

102204

1.39

181.85

5.0

3.8

0.00

estimate

0.52

4157

20080

(3037467) Urinalysis macro (dipstick) panel - Urine

23861

132465

1.41

180.05

5.7

4.5

1.65

61.00

0.51

227

(3024928) Oxygen saturation in Venous blood

1629

4661

2.26

177.80

4.6

2.5

63.68

61.04

4.37

1567

4509

(42870588) Differential panel, method unspecified - Blood

13443

67906

1.40

176.25

6.9

6.4

3.48

5.17

—

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

8657

40451

1.46

173.92

1.9

1.7

44476002.65

30676862.99

pmol/l

1.03

7141

33071

(3019069) Monocytes/Leukocytes in Blood

17352

91616

1.38

173.46

7.4

6.7

9.17

9.00

10.86

16381

85551

(3006504) Eosinophils/Leukocytes in Blood

17307

91344

1.38

173.37

7.3

6.6

2.89

2.87

0.86

16345

85251

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

4755

19512

1.62

172.80

4.3

3.3

—

(3006576) Bicarbonate [Moles/volume] in Blood

337

324

6.61

170.19

7.7

4.3

25.46

24.92

mmol/l

0.97

307

305

(3015736) pH of Urine

15771

82145

1.38

169.97

4.3

3.4

6.24

6.19

6.04

8551

44953

(3029937) Albumin [Presence] in Urine by Test strip

11320

55835

1.41

168.18

5.3

4.0

0.00

estimate

0.31

3760

18380

(3042733) HLA Ab [Presence] in Serum

356

371

6.10

167.59

5.3

5.1

—

(3022096) Basophils/Leukocytes in Blood

17267

91476

1.37

165.97

7.4

6.7

0.67

0.69

4.91

16308

85326

(3033658) Prothrombin time (PT) actual/Normal

10630

51999

1.41

164.75

5.4

4.0

84.69

90.84

110.99

10392

50908

(3011397) Hemoglobin [Presence] in Urine by Test strip

9800

47428

1.42

160.39

4.6

3.7

0.30

0.26

0.10

507

(3027315) Oxygen [Partial pressure] in Blood

1311

3564

2.37

160.35

5.0

3.5

8.47

8.64

kpa

2.64

1287

3470

(3026782) Osmolality of Urine

8112

37948

1.45

159.54

3.6

2.8

511.59

541.13

mosm/kgh2o

27.69

7165

33185

(3026250) Tacrolimus [Mass/volume] in Blood

445

610

4.64

158.97

44.5

36.5

7.44

6.94

ug/l

3.77

406

534

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

9982

48527

1.41

158.96

3.0

2.4

—

(3028271) Lactate [Moles/volume] in Capillary blood

1045

2559

2.62

158.51

2.0

1.7

1.71

1.77

mmol/l

0.90

1023

2476

(3020630) Protein [Mass/volume] in Serum or Plasma

4288

17526

1.62

157.11

2.6

2.8

65.63

66.48

g/l

10.21

3995

15931

(3002030) Lymphocytes/Leukocytes in Blood

17505

93523

1.35

154.91

7.4

6.6

25.72

27.51

81.70

16672

88333

(1616796) Gas panel - Central venous blood

1387

3931

2.27

154.41

5.0

3.4

—

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

1636

4967

2.13

154.27

3.0

2.3

3.63

3.70

g/l

0.94

1593

4758

(3019150) Specific gravity of Urine by Refractometry

9089

43644

1.42

154.17

5.3

4.0

1.02

1.09

kg/l

0.82

6258

29150

(3013290) Carbon dioxide [Partial pressure] in Blood

1294

3560

2.34

154.09

5.0

3.5

4.99

5.01

kpa

0.48

1270

3467

(3012501) Base excess in Blood by calculation

1293

3560

2.34

153.70

5.0

3.5

2.44

2.65

mmol/l

1.59

887

2470

(3018010) Neutrophils/Leukocytes in Blood

17165

91737

1.35

149.21

7.2

6.5

58.85

57.32

51.22

16481

87241

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

3803

15393

1.62

144.01

5.5

3.6

120.24

82.32

ng/l

59.00

3316

13150

(3010421) pH of Blood

1774

5702

2.01

143.81

5.0

3.1

7.41

0.61

1755

5612

(3006184) Hemoglobin [Mass/volume] in Capillary blood

1467

4457

2.12

137.83

2.7

2.1

127.56

130.42

g/l

3.56

1167

3280

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

14425

75758

1.34

136.17

5.0

3.7

0.49

0.61

estimate

0.17

3475

16172

(4010399) Spirometry for bronchospasm with prolonged evaluation after bronchodilator

3688

15046

1.61

134.67

1.5

—

(3013707) Erythrocyte sedimentation rate [Velocity] in Red Blood Cells by Westergren method

25240

144139

1.36

132.63

5.4

4.3

14.84

12.45

mm/h

92.12

23703

133965

(3036481) Cortisol [Moles/volume] in Serum or Plasma

4079

17103

1.57

132.62

2.2

2.5

369.75

381.71

nmol/l

2.96

3774

15875

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

5237

23218

1.49

131.80

2.8

8.24

9.72

umol/l

5.40

4642

20496

(3021589) Normoblasts [#/volume] in Blood

16011

85817

1.32

128.53

15.5

11.2

0.00

e9/l

0.14

13167

69290

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

1450

4570

2.04

123.62

1.6

1.5

—

(40768797) Stomach Pathology biopsy report

5966

27527

1.44

121.36

1.3

—

(3022806) Fractional oxyhemoglobin in Capillary blood

781

1896

2.63

120.32

1.9

1.7

89.08

89.55

1.18

769

1868

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

1469

4699

2.01

120.27

1.7

1.6

—

(3045716) Anion gap in Serum or Plasma by calculation

738

1786

2.64

114.37

4.0

2.9

11.12

10.70

mmol/l

1.98

730

1768

(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal

748

1834

2.60

113.02

1.3

1.4

1.57

1.37

nmol/l

3.83

667

1655

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

1692

5839

1.87

111.02

1.3

—

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

7523

36681

1.37

109.72

3.5

3.0

1.10

1.19

e6/l

0.45

4254

19051

(40758558) Short blood count panel - Blood

11546

60227

1.31

105.93

6.8

—

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

1939

7113

1.76

104.23

3.0

3.7

47.16

41.27

mg/l

0.44

1613

6135

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

30626

182415

1.42

103.80

9.6

6.3

42.82

39.23

mmol/mol

307.65

29085

168755

(3034860) Kappa light chains.free [Mass/volume] in Serum

1936

7123

1.75

102.99

3.0

3.7

82.89

66.08

mg/l

0.24

1611

6142

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

30003

178164

1.40

102.08

6.2

4.2

1.39

1.32

mmol/l

45.21

28124

161546

(3036489) Thrombin time

1815

6580

1.78

101.47

2.7

1.7

21.87

20.81

5.61

1657

5817

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

31311

187390

1.45

101.43

26.0

15.4

25.76

26.03

mg/l

0.73

27859

153304

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

918

2613

2.25

100.81

7.5

5.7

11.99

11.76

mg/l

0.79

840

2430

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

24943

144198

1.30

100.76

4.9

4.3

15.06

14.87

pmol/l

25.82

23006

130984

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

1249

4024

1.99

100.03

1.6

1.4

—

(3009445) Proteinase 3 Ab [Units/volume] in Serum

2149

8208

1.69

100.01

1.4

1.6

12.71

16.12

iu/ml

0.30

217

(21494755) Public health laboratory ask at order entry panel

1409

15611

0.55

99.43

1.4

—

(40760888) Immunoglobulin light chains.free panel - Serum

1354

4515

1.93

98.29

2.9

3.9

0.92

1.18

—

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

1726

6312

1.76

93.54

2.9

3.7

3.18

6.99

ratio

1.17

989

3628

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

1398

4821

1.86

91.65

3.3

2.2

214.11

197.39

8.40

1342

4549

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

772

2125

2.32

91.53

1.6

1.5

—

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

4972

23279

1.40

90.25

10.5

6.0

—

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

1879

7113

1.70

90.10

2.8

2.6

—

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

3518

15478

1.48

89.07

5.3

3.7

1.22

1.23

mmol/l

18.65

3086

13169

(3040151) Glucose [Moles/volume] in Capillary blood

712

1920

2.36

88.35

6.8

8.8

7.72

7.46

mmol/l

0.80

602

1585

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

1915

18994

0.61

87.20

2.5

2.1

3.36

3.58

ratio

5.86

1615

15316

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

1057

3369

2.01

87.11

1.5

1.4

—

(3000492) Spirometry study

3972

17982

1.44

86.63

1.6

1.5

—

17.22

—

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

1483

5313

1.79

85.99

3.0

1.9

89.70

93.62

8.51

1445

5077

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

905

2747

2.10

84.87

1.5

1.4

—

(44806118) Parainfluenza type 4 nucleic acid detection

762

2162

2.25

84.28

1.6

1.4

—

(44790048) Parainfluenza type 2 nucleic acid detection

762

2163

2.25

84.19

1.6

1.4

—

(44790049) Parainfluenza type 3 nucleic acid detection

762

2163

2.25

84.19

1.6

1.4

—

(44790047) Parainfluenza type 1 nucleic acid detection

762

2164

2.25

84.10

1.6

1.4

—

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

1559

5721

1.75

83.32

4.0

2.7

1.90

1.49

mg/l

47.69

1437

5197

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

1060

3437

1.97

83.27

1.5

1.4

—

(3000012) Reticulocyte production index

869

2618

2.12

83.07

2.0

2.4

0.92

0.90

0.53

609

1764

(3037522) Nuclear Ab [Titer] in Serum

5345

25653

1.37

82.87

1.4

1.3

542.58

522.31

titre

0.31

1203

5468

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

1522

5575

1.75

81.83

2.0

1.6

—

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

1032

3336

1.98

81.76

1.8

1.4

—

(3005719) IgG [Mass/volume] in Serum or Plasma

3290

14530

1.47

81.29

2.8

3.0

10.40

10.66

g/l

2.66

3074

13331

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

1172

3974

1.89

80.79

8.2

4.5

1812.90

2370.42

iu/ml

0.15

233

517

(3028026) IgM [Mass/volume] in Serum or Plasma

2657

11259

1.53

80.09

1.9

2.0

1.20

1.38

g/l

3.43

2463

10258

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

931

2943

2.02

78.44

1.8

1.4

155.89

150.82

au/ml

0.59

263

904

(3030981) Hyaline casts [#/volume] in Urine by Automated count

3670

16666

1.43

78.17

2.9

2.4

0.52

0.41

e6/l

1.71

3558

15954

(3023183) Ammonium ion [Moles/volume] in Plasma

1253

4392

1.83

77.90

2.6

2.7

31.80

34.92

umol/l

4.20

1131

3939

(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum

1784

6921

1.66

77.81

1.3

—

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

1286

4551

1.81

77.52

1.5

1.6

—

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

4343

20370

1.39

76.91

2.2

2.3

0.20

0.21

g/l

4.31

4006

18975

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

758

2238

2.16

76.20

1.6

1.4

—

(3024932) HLA-DR beta [Type]

255

407

3.97

76.08

1.0

1.2

—

(3022313) Gas panel - Capillary blood

2213

9119

1.56

75.42

4.7

3.4

—

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

6730

33850

1.31

75.24

3.6

3.1

2.34

2.52

e6/l

0.65

3473

16094

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

914

2916

2.00

75.08

1.3

1.5

9.69

18.25

u/ml

1.43

(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma

1008

3337

1.93

74.57

1.7

1.4

17.97

22.12

u/ml

0.44

(42868678) Cholesterol non HDL [Moles/volume] in Serum or Plasma

1293

13600

0.58

74.15

2.0

1.8

2.72

3.56

mmol/l

97.49

1001

9748

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

971

3188

1.95

73.57

1.7

—

(3024471) HLA-A [Type]

257

424

3.84

73.46

1.0

—

(3017143) Hepatitis C virus Ab [Presence] in Serum

3851

17833

1.41

73.20

1.9

1.6

—

(3017181) Myelocytes/Leukocytes in Blood

3803

17574

1.41

73.16

4.5

4.4

0.94

1.01

0.85

1247

5689

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

900

2883

1.99

73.10

1.4

1.2

282.85

272.63

u/ml

0.41

601

1759

(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

938

3059

1.96

72.45

3.3

2.3

2838.87

6140.03

u/ml

0.45

191

(3002179) Metamyelocytes/Leukocytes in Blood

3632

16732

1.41

70.97

4.3

0.73

0.75

0.08

1167

5460

(3015377) Calcium [Moles/volume] in Serum or Plasma

13030

71453

1.24

70.28

3.6

3.8

2.35

2.36

mmol/l

11.82

11857

64468

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

2494

10725

1.50

69.78

3.2

3.5

4.32

4.48

pmol/l

13.51

2242

9520

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

4121

19452

1.38

69.69

3.0

2.5

45.12

53.39

u/l

0.48

3476

16439

(3003434) Protein [Mass/volume] in Pleural fluid

842

2681

2.00

69.54

1.5

1.4

29.36

46.33

g/l

0.90

749

2473

(3029080) Hemoglobin [Entitic mass] in Reticulocytes

779

2431

2.04

67.94

2.1

2.3

32.19

32.64

2.02

771

2414

(3010375) cycloSPORINE [Mass/volume] in Blood

318

643

3.14

67.68

29.6

28.8

109.32

109.83

ug/l

0.04

237

558

(3022493) Free Hemoglobin [Mass/volume] in Plasma

321

661

3.08

66.35

11.3

1.3

1900.88

2387.83

mg/l

0.14

244

440

(3021440) Promyelocytes/Leukocytes in Blood

3609

16800

1.39

66.09

4.5

4.4

0.10

0.13

1.11

1055

4942

(3025159) Blasts/Leukocytes in Blood

3618

16865

1.39

65.70

4.6

0.15

0.36

2.85

1011

4710

(3020876) Protein [Mass/time] in 24 hour Urine

768

2425

2.02

64.90

2.5

2.3

1.36

1.22

g/24h

0.69

481

1433

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

928

3151

1.88

63.64

1.4

1.2

62.60

38.44

u/ml

0.34

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

29098

174550

1.28

63.21

6.2

5.2

2.00

1.95

mu/l

6.45

27095

159608

(3016750) Collection duration of Urine

386

919

2.67

61.85

2.7

2.0

498.86

495.23

min

0.27

299

669

(3004775) Volume in Urine collected for unspecified duration

489

1321

2.35

60.53

2.8

2.1

724.32

673.53

1.60

355

872

(40761536) Microorganisms panel - Urine sediment

3147

14528

1.40

60.18

5.5

3.9

—

(3011648) Oxygen content in Venous blood

648

1983

2.08

59.53

2.3

1.9

10.51

11.00

1.97

643

1975

(3017817) Protein [Mass] in Urine collected for unspecified duration

556

1604

2.20

59.19

2.3

2.7

1123.14

976.72

0.99

549

1593

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

7656

40162

1.26

59.16

1.4

1.3

1.65

1.82

u/ml

0.49

2043

10079

(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence

983

3482

1.80

58.99

1.3

86.67

112.75

titre

0.37

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

4160

20153

1.34

58.83

1.9

1.5

—

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

1360

5285

1.65

58.69

1.8

1.6

0.24

g/l

1.36

1303

5033

(40757494) Bilirubin.total [Moles/volume] in Blood

340

782

2.76

58.13

2.0

2.2

28.39

24.90

umol/l

0.10

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

975

3468

1.79

57.72

1.3

290.29

276.67

titre

0.06

267

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

1389

5459

1.63

57.32

1.8

1.6

1.20

g/l

0.14

1331

5226

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

1162

4362

1.70

57.09

1.6

1.4

—

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

7891

41715

1.25

56.55

2.9

3.3

2.46

mmol/l

1.52

6986

37505

(3023419) Bacteria identified in Sputum by Culture

742

2432

1.94

56.51

2.2

2.6

—

(3027653) Mycophenolate [Mass/volume] in Serum or Plasma

11.05

55.87

2.4

2.22

2.66

mg/l

0.57

(3007164) IgA [Mass/volume] in Serum or Plasma

6783

35299

1.26

55.58

1.6

1.5

2.70

2.57

g/l

4.55

4112

20751

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

477

1333

2.27

54.75

1.5

—

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

1258

4880

1.65

54.63

1.9

2.0

12.39

11.80

mg/l

0.71

1171

4554

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

15033

85010

1.20

54.53

2.3

1.9

1.40

1.37

mmol/l

2.80

12651

70017

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

1009

3689

1.75

54.43

1.4

1.3

—

(3032700) Glomerular basement membrane Ab [Units/volume] in Serum

613

1901

2.05

54.41

1.1

1.3

25.63

66.97

u/ml

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

1009

3690

1.74

54.38

1.4

1.3

—

(3023199) Leukocytes [#/volume] in Pleural fluid

731

2425

1.92

53.76

1.5

1.4

3246.51

3598.47

e6/l

0.10

512

1704

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

512

1487

2.19

53.67

2.3

2.4

23.11

28.66

iu/ml

0.64

198

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

13614

76359

1.20

53.66

5.2

5.5

2.33

3.32

ug/l

7.32

12342

69772

(3017569) Oxygen content in Arterial blood

370

928

2.53

53.62

2.2

2.3

15.95

15.85

0.20

370

928

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

440

5765

0.47

52.06

1.2

1.1

0.57

0.64

ratio

3.27

117

906

(3052851) Hemolysis interference index of Serum or Plasma

1355

5432

1.60

51.54

4.0

3.1

1.76

2.27

index

2.10

725

2598

(3003181) Sodium [Moles/volume] in Urine

1034

3881

1.70

50.81

1.4

1.3

57.62

61.43

mmol/l

2.38

822

3061

(3034770) Mitochondria Ab [Titer] in Serum

1320

5280

1.60

50.67

1.2

822.59

900.18

titre

0.19

164

(3048929) Epstein Barr virus Ab [Presence] in Serum

1096

4190

1.67

50.31

1.4

1.2

—

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

1840

7984

1.48

48.78

1.9

2.0

38.57

40.24

u/l

2.47

1531

7164

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

1098

4259

1.64

47.67

1.7

1.6

—

(3044242) Glucose [Moles/volume] in Arterial blood

348

902

2.45

47.20

2.1

2.0

8.41

8.06

mmol/l

0.82

348

902

(3007566) Smooth muscle Ab [Titer] in Serum

1322

5384

1.57

47.01

1.2

107.87

139.09

titre

0.82

136

473

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

940

3519

1.70

46.63

1.2

1.3

32.37

35.63

u/l

0.35

827

3036

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

1675

7202

1.49

46.42

4.8

3.5

24.73

24.98

mmol/l

2.72

1542

6566

(3037756) Immunofixation for Serum or Plasma

1134

4465

1.62

46.40

1.5

1.8

—

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

2010

8957

1.44

46.38

2.4

2.5

3.73

3.76

g/l

0.37

1865

8086

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

2009

8978

1.44

45.64

2.4

2.5

4.20

4.23

g/l

0.54

1865

8108

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

2010

8992

1.43

45.39

2.4

2.5

7.66

7.37

g/l

10.72

1866

8107

(3036782) Glucose [Moles/volume] in Pleural fluid

576

1868

1.96

45.28

1.4

1.3

7.05

5.97

mmol/l

14.24

537

1733

(3045788) Cell count panel - Pleural fluid

587

1918

1.94

45.17

1.5

—

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

6467

34154

1.24

45.14

1.4

1.3

36.55

40.67

iu/ml

0.85

2019

10564

(3000570) Elastase.pancreatic [Mass/mass] in Stool

1506

6372

1.51

45.07

1.5

1.4

258.23

263.87

ug/g

0.46

919

3742

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

402

1144

2.23

44.33

1.3

1.2

82.55

80.55

0.21

(3011985) Renin [Units/volume] in Plasma

784

2831

1.76

44.16

1.4

1.5

93.15

57.02

mu/l

2.57

699

2528

(3015171) Extractable nuclear Ab [Units/volume] in Serum

1575

6779

1.49

43.39

1.2

1.26

0.84

u/ml

0.55

139

511

(3025941) Bacteria identified in Stool by Culture

2040

9263

1.41

42.36

1.3

1.2

—

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

1744

7700

1.45

42.20

2.4

2.5

9.89

10.24

g/l

2.71

1576

6742

(40763082) Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction

565

1866

1.92

42.18

1.3

285.03

601.64

u/l

6.76

538

1776

(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma

751

2717

1.76

42.04

1.3

0.18

0.26

nmol/l

0.94

197

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

6012

31722

1.23

41.91

1.3

12.34

13.43

u/ml

0.50

2198

11621

(21494890) Protein electrophoresis panel - 24 hour Urine

613

2085

1.87

41.90

1.9

2.3

—

(3052318) Alpha-1-Microglobulin [Mass/volume] in Urine

146

242

3.81

41.71

3.4

2.4

52.72

46.57

mg/l

0.15

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

1896

8543

1.42

41.09

2.4

2.5

2.97

2.88

g/l

3.30

1753

7663

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

30480

185674

1.25

41.05

7.0

5.2

6.38

5.97

mmol/l

307.65

28357

169317

(46235355) HIV 1 and 2 tests - Meaningful Use set

4405

22561

1.26

39.80

1.9

1.6

—

(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration

311

833

2.37

39.41

2.2

2.1

209.71

64.76

ug/min

1.07

172

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

719

2626

1.74

38.98

1.3

280.79

298.12

pmol/l

0.50

583

2254

(3000494) Fungus identified in Specimen by Culture

4760

24664

1.25

38.82

1.6

1.4

—

(3018461) Alpha 1 globulin [Mass/time] in 24 hour Urine by Electrophoresis

131

212

3.91

38.65

7.1

4.9

43.74

47.22

ug/min

0.21

111

162

(3028308) Erythrocytes [#/volume] in Pleural fluid

620

2174

1.81

38.54

1.5

55090.26

58242.59

e6/l

0.08

355

1233

(3026179) Normetanephrine [Moles/volume] in Serum or Plasma

729

2683

1.73

38.48

1.3

2.07

2.01

nmol/l

0.01

698

2590

(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

141

244

3.65

38.05

5.6

6.0

3571.57

4589.62

iu/ml

0.13

(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum

1327

5671

1.49

37.82

1.6

1.5

11.47

16.77

iu/ml

1.11

129

(42529406) Shigella sp [Presence] in Stool by Culture

1145

4752

1.54

37.44

1.2

—

(3014765) Yersinia sp identified in Stool by Organism specific culture

1143

4746

1.54

37.29

1.2

—

(3005757) Coagulation factor V activity actual/normal in Platelet poor plasma by Coagulation assay

307

844

2.30

36.76

2.1

2.0

96.82

100.25

0.70

298

801

(40768446) Kidney Pathology biopsy report

268

694

2.45

36.55

1.9

1.6

—

(3045414) Leukocytes [Presence] in Urine

3841

19541

1.27

36.47

2.4

2.1

0.01

0.02

estimate

0.50

688

3729

(3042631) Mycobacterium sp identified in Specimen

716

2664

1.71

36.38

2.6

—

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

991

4008

1.57

36.30

3.2

1.6

0.96

0.83

nmol/l

5.13

827

3404

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

15604

90378

1.16

36.17

2.7

2.4

76.85

1092.60

nmol/l

0.50

14043

80899

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

205

465

2.79

36.17

1.1

—

(3035715) Granulocytes [#/volume] in Blood

850

3324

1.63

35.78

3.4

3.3

4.33

4.06

e9/l

2.76

850

3316

(40763091) Bacteria identified in Peritoneal dialysis fluid by Culture

6.70

35.71

3.8

3.1

—

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

1130

4725

1.52

35.70

1.2

—

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

1470

6498

1.44

35.28

2.4

2.5

0.04

0.03

g/l

0.17

1339

5831

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

2891

22991

0.77

34.76

1.4

—

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

624

2264

1.75

34.66

1.3

—

nmol/l

—

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

1416

6246

1.45

34.37

2.4

2.5

0.00

g/l

0.69

1264

5467

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

1336

5844

1.46

33.87

2.5

2.6

0.00

g/l

-0.00

1260

5457

(3019550) Sodium [Moles/volume] in Serum or Plasma

32008

196699

1.26

33.80

33.9

17.6

139.48

139.75

mmol/l

59.85

31713

192551

(3001019) Free T4 and TSH panel - Serum or Plasma

735

7340

0.62

33.37

1.6

1.7

—

(3008037) Lactate [Moles/volume] in Venous blood

1094

4625

1.51

32.84

4.2

2.7

1.65

1.57

mmol/l

1.56

1055

4529

(3022764) Mononuclear cells/Leukocytes in Peritoneal fluid

14.02

32.74

9.3

6.9

47.00

60.88

—

(3005322) IgE [Units/volume] in Serum or Plasma

2271

10959

1.33

32.01

1.3

228.39

275.14

u/ml

1.32

2099

10196

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

632

2355

1.70

31.99

1.3

0.22

0.19

nmol/l

0.49

497

1883

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

1680

7738

1.39

31.96

2.2

2.0

—

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

504

1759

1.82

31.89

3.5

2.6

—

(3040562) Leukocytes [#/volume] in Peritoneal dialysis fluid by Manual count

12.32

31.55

9.6

6.2

—

(40768806) Pleura Pathology biopsy report

577

2112

1.73

31.13

1.5

—

(3041096) Erythrocytes [Presence] in Urine by Automated

9534

53655

1.16

31.04

4.4

3.3

0.19

0.35

estimate

0.70

3325

15677

(3029856) Leukocytes [#/volume] in Peritoneal dialysis fluid

6.53

30.92

10.9

10.8

146.02

244.15

e6/l

0.67

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

1555

7131

1.39

30.35

2.0

1.8

—

(3007302) Hemoglobin [Mass/volume] in Mixed venous blood

9.36

30.33

13.3

22.8

106.74

105.23

g/l

0.19

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

10782

61353

1.15

30.03

4.5

4.4

23.06

21.56

17.53

5059

29829

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

1295

5767

1.43

29.86

1.3

—

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

1677

7813

1.37

29.74

2.5

2.6

0.69

0.92

g/l

1.88

1475

6655

(3005532) Lymphocytes/Leukocytes in Pleural fluid

225

593

2.40

29.68

1.5

1.4

62.75

62.32

0.06

183

493

(3014148) Varicella zoster virus Ab [Titer] in Serum

504

1801

1.77

29.55

1.1

—

(3049717) Cytology report of Urine Cyto stain

1755

8244

1.36

29.55

2.7

2.8

—

(3023103) Potassium [Moles/volume] in Serum or Plasma

32015

197141

1.24

29.19

34.2

17.8

4.03

3.98

mmol/l

282.93

31702

192699

(3026389) Candida sp identified in Specimen by Organism specific culture

647

2499

1.64

28.67

1.5

1.4

—

(43055442) Apixaban [Mass/volume] in Serum or Plasma

127

252

3.18

28.17

1.6

1.4

119.84

115.92

ug/l

0.13

109

189

(4034850) Laboratory test

1258

5634

1.42

28.12

15.2

8.9

—

(3027923) C peptide [Moles/volume] in Serum or Plasma

344

1104

1.97

28.07

1.4

1.20

1.25

nmol/l

0.27

254

812

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

350

1136

1.95

27.67

1.8

1.9

—

(3023420) DNA double strand Ab [Units/volume] in Serum

1645

7737

1.36

27.46

2.0

1.7

8.94

7.39

iu/ml

0.96

382

1697

(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay

222

612

2.29

26.59

2.1

2.3

175.73

159.47

1.64

210

569

(3003694) ABO and Rh group [Type] in Blood

9278

52596

1.15

26.44

1.4

1.3

—

(3037441) Creatinine [Moles/volume] in Peritoneal dialysis fluid

7.41

26.41

6.1

5.2

396.45

430.53

umol/l

0.41

(3035880) pH of Pleural fluid

316

1009

1.98

26.19

1.3

7.43

7.39

2.90

238

700

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

207

557

2.35

26.18

3.2

2.5

9.87

10.38

kpa

1.51

207

557

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

344

1132

1.92

26.17

1.5

1.4

—

(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal

391

1347

1.84

25.89

1.2

10.51

9.49

mmol/l

3.92

354

1251

(3000093) Morphology [Interpretation] in Blood Narrative

503

1868

1.71

25.87

1.2

1.1

—

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

206

557

2.34

25.78

3.2

2.5

4.94

4.95

kpa

0.03

206

557

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

324

1055

1.94

25.43

1.5

—

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

30516

187403

1.19

25.35

7.3

5.0

1.32

1.48

mmol/l

307.65

28864

171820

(3021879) Hepatitis B virus core Ab [Presence] in Serum

2425

12187

1.27

25.05

1.5

1.4

—

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

299

952

1.99

25.01

1.1

—

(3009595) Pneumocystis jirovecii DNA [Presence] in Specimen by NAA with probe detection

420

1499

1.78

24.82

1.8

1.4

—

(3017732) Neutrophils [#/volume] in Blood

4655

25092

1.19

24.71

3.3

5.08

4.51

e9/l

3.13

4067

21111

(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

1074

4789

1.43

24.62

1.3

1.2

29.23

11.04

u/ml

0.62

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

311

1018

1.93

24.07

1.5

—

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

654

2658

1.56

23.59

1.1

1.58

1.53

g/l

2.42

604

2409

(3014051) Protein [Presence] in Urine by Test strip

9706

55596

1.14

23.06

3.5

2.9

0.11

0.07

0.56

214

1376

(3012565) Volume of 24 hour Urine

269

850

2.00

23.02

2.3

2.2

1780.03

2047.84

3.10

239

765

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

382

1366

1.77

22.49

1.2

—

(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)

249

774

2.04

22.30

1.5

1.6

23.99

7.96

nmol/l

0.36

214

649

(3038515) Glucose [Moles/volume] in Venous blood

898

3948

1.44

22.25

4.5

2.8

7.97

7.55

mmol/l

3.27

865

3872

(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid

415

1528

1.72

22.10

1.3

12.25

15.07

u/l

1.41

370

1429

(3048689) Calprotectin [Mass/mass] in Stool

4223

22812

1.19

21.67

2.2

2.4

166.49

143.83

ug/g

3.07

3407

18074

(3017704) Immunofixation for Urine

313

1067

1.86

21.52

1.4

1.8

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

435

1644

1.68

21.09

1.6

1.7

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

435

1644

1.68

21.09

1.6

1.7

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

435

1644

1.68

21.09

1.6

1.7

—

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

1107

5099

1.38

21.08

1.5

1.3

—

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

30640

188725

1.17

20.87

7.4

5.1

3.93

4.77

mmol/l

307.65

29164

174275

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

549

2211

1.57

20.66

1.2

58.44

63.19

u/l

0.97

482

1937

(1761868) Lipid panel - Serum or Plasma

10590

72406

0.89

20.57

4.4

3.2

—

(3003129) Base excess in Capillary blood by calculation

620

2570

1.53

20.55

2.5

2.1

0.33

0.59

mmol/l

0.89

591

2488

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

621

2576

1.53

20.51

1.3

1.2

4.10

3.60

u/ml

0.22

230

959

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

693

2946

1.49

20.40

1.1

44.83

5085.53

iu/ml

0.66

124

543

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

21272

128146

1.12

20.24

4.0

3.3

61.99

52.23

u/l

28.93

19928

119473

(3051651) Icteric interference index of Serum or Plasma

294

1003

1.85

20.20

4.4

3.5

0.87

0.93

index

0.40

286

972

(4062490) Immunoglobulin typing, IgG

478

1876

1.61

20.04

1.4

—

(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum

1823

9090

1.28

20.01

1.1

13.14

6.32

u/ml

0.23

(3000034) Microalbumin [Mass/volume] in Urine

447

1728

1.64

19.91

3.2

3.0

84.08

43.76

mg/l

1.40

327

1248

(43055246) Days in therapeutic INR range/Days INR result determined [Ratio]

127

310

2.59

19.79

6.9

7.5

68.23

72.39

0.75

226

(3024980) IgG subclass 4 [Mass/volume] in Serum

737

3193

1.46

19.76

1.6

0.74

0.85

g/l

1.32

557

2488

(3016650) Hepatitis A virus Ab [Presence] in Serum

700

3003

1.48

19.72

1.1

—

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

271

909

1.89

19.63

3.6

3.9

—

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

606

2527

1.52

19.57

1.3

1.2

5.11

3.51

u/ml

1.29

312

1146

(3042111) Morphology [Interpretation] in Bone marrow Narrative

786

3479

1.43

18.85

1.6

1.7

—

(3002385) Erythrocyte [DistWidth] in Red Blood Cells

25361

154527

1.12

18.81

31.6

19.3

14.00

13.66

244.47

25148

152349

(3037121) Protein [Mass/volume] in Urine

1419

6906

1.31

18.76

3.4

458.77

501.76

mg/l

0.24

701

3180

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

1208

5749

1.34

18.69

1.4

—

(3033923) Metanephrine [Moles/time] in 24 hour Urine

131

335

2.47

18.63

1.1

0.73

0.66

umol/24h

0.64

163

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

1410

6865

1.31

18.59

1.6

24.43

21.19

u/ml

0.58

231

1491

(3027135) IgG subclass 1 [Mass/volume] in Serum

479

1920

1.58

18.45

1.4

6.74

6.83

g/l

0.18

347

1366

(3028029) Mesothelial cells/Leukocytes in Pleural fluid

107

248

2.72

18.43

1.4

12.67

12.82

0.02

128

(3024139) IgG subclass 3 [Mass/volume] in Serum

478

1917

1.58

18.38

1.4

0.44

0.41

g/l

0.66

348

1366

(3028192) IgG subclass 2 [Mass/volume] in Serum

478

1920

1.58

18.26

1.4

2.74

2.96

g/l

2.08

350

1367

(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma

348

3580

0.61

18.08

3.4

3.8

30.19

43.91

u/ml

2.35

335

3481

(3016038) Potassium [Moles/volume] in Urine

367

1385

1.68

17.98

1.1

36.25

33.51

mmol/l

1.37

319

1193

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

131

341

2.43

17.97

1.5

1.3

1.18

mmol/l

0.33

131

341

(40768804) Tissue Pathology biopsy report

12091

81610

0.90

17.79

2.2

—

(3014891) Appearance of Pleural fluid

221

2.80

17.75

1.7

1.6

—

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

1209

5801

1.32

17.70

1.6

1.5

6.89

7.09

iu/ml

0.01

234

1067

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

498

2035

1.55

17.68

1.6

1.8

—

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

222

722

1.94

17.67

2.5

2.9

0.61

mmol/l

0.04

222

722

(3015401) Amylase [Enzymatic activity/volume] in Pleural fluid

104

243

2.70

17.67

1.3

41.67

346.19

u/l

0.98

180

(3051611) Lipemic interference index of Serum or Plasma

480

1947

1.56

17.60

4.3

3.2

13.46

14.43

index

0.47

287

972

(3011335) Digoxin [Mass/volume] in Serum or Plasma

3.81

16.87

2.8

2.1

0.62

0.68

ug/l

0.56

(3000963) Hemoglobin [Mass/volume] in Blood

32095

205337

0.85

16.81

39.9

23.6

132.80

136.25

g/l

267.05

31859

202787

(3010813) Leukocytes [#/volume] in Blood

32094

205322

0.85

16.71

39.6

23.5

7.18

6.65

e9/l

222.56

31517

199432

(3026361) Erythrocytes [#/volume] in Blood

32092

205307

0.85

16.68

39.5

23.5

4.41

4.51

e12/l

191.08

31515

199391

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

467

1908

1.55

16.62

1.7

1.8

—

(42870325) Hepcidin 25 amino acid peptide [Moles/volume] in Serum or Plasma

194

2.86

16.62

1.2

1.4

6.43

369948.00

nmol/l

1.75

163

(3039162) Centromere protein B Ab [Units/volume] in Serum

538

2267

1.50

16.62

1.3

1.2

65.27

62.66

u/ml

0.08

118

(3009542) Hematocrit [Volume Fraction] of Blood by calculation

32092

205301

0.85

16.61

40.8

23.9

39.85

40.97

29.93

31847

202623

(3024731) MCV [Entitic mean volume] in Red Blood Cells

32092

205297

0.85

16.56

39.4

23.4

91.72

91.41

27.29

31853

202713

(3035941) MCH [Entitic mass]

32091

205281

0.85

16.45

39.4

23.4

30.41

30.44

2.35

31853

202698

(3008116) Ketones [Moles/volume] in Urine by Test strip

144

408

2.23

16.42

1.6

1.4

0.24

0.30

mmol/l

0.29

(4195642) Thrombophilia screening test

566

2419

1.48

16.34

1.3

1.2

—

(3001893) Eosinophils/Leukocytes in Pleural fluid

170

517

2.08

16.29

1.5

1.4

3.30

2.46

0.53

144

444

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

581

5252

0.69

16.23

1.4

1.3

—

(3004716) Salmonella sp identified in Stool by Organism specific culture

1436

7145

1.28

16.06

1.3

1.4

—

(3044927) Protein electrophoresis panel - Urine

498

2080

1.52

16.06

1.2

—

(40768793) Breast Pathology biopsy report

524

4817

0.68

16.05

1.3

—

(44816559) Phosphatidylethanol [Mass/volume] in Blood

1543

7752

1.27

15.95

1.7

0.35

0.33

mg/l

0.83

787

3971

(3017315) Amylase [Enzymatic activity/volume] in Urine

271

973

1.76

15.91

1.3

1.2

249.54

375.59

u/l

1.36

245

900

(3007461) Platelets [#/volume] in Blood

32092

205232

0.85

15.85

39.6

23.5

239.63

249.51

e9/l

131.21

31640

200199

(40763641) Cell count and Differential panel - Peritoneal dialysis fluid

8.20

15.75

3.3

2.8

—

(3052649) Adenosine deaminase [Enzymatic activity/volume] in Serum or Plasma

376

1479

1.61

15.75

1.5

1.4

14.52

12.54

u/l

5.53

363

1425

(4268621) Lupus anticoagulant assay

438

1790

1.55

15.61

2.3

—

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

157

472

2.10

15.52

1.4

1.1

—

(3047352) Trisomy 18 risk [Likelihood] in Fetus

405

0.14

15.42

1.6

1.4

—

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

242

849

1.80

15.37

1.2

—

(3000919) Neutrophils/Leukocytes in Pleural fluid

155

468

2.09

15.17

1.5

1.3

20.73

21.81

0.18

140

428

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

699

3158

1.40

15.05

1.1

—

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

31040

192092

1.15

15.03

8.7

5.8

2.10

2.81

mmol/l

307.65

29498

176569

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

830

3860

1.36

15.01

1.3

1.2

—

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

1241

9906

0.78

14.98

3.4

4.3

66.81

68.71

u/ml

0.05

1195

9570

(3042010) Triglyceride [Moles/volume] in Pleural fluid

112

296

2.39

14.97

1.3

1.2

1.20

1.60

mmol/l

0.26

204

(3035285) Chloride [Moles/volume] in Venous blood

491

2077

1.50

14.95

2.9

2.1

105.53

105.46

mmol/l

0.13

486

2064

(3041354) Potassium [Moles/volume] in Venous blood

491

2078

1.50

14.91

2.9

2.1

4.12

4.04

mmol/l

3.15

486

2065

(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay

557

2424

1.46

14.72

1.2

1.1

112.88

119.92

4.79

512

2177

(3020961) Endomysium IgA Ab [Titer] in Serum

1488

7525

1.26

14.57

1.1

180.90

203.21

titre

0.16

206

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

703

3200

1.39

14.51

1.2

0.44

1.11

3.33

118

(3022145) Colonoscopy Study observation

4354

24298

1.15

14.35

1.4

—

(3041918) Cholesterol [Moles/volume] in Pleural fluid

125

354

2.23

14.34

1.2

1.35

1.79

mmol/l

3.40

225

(3009871) Measles virus Ab [Titer] in Serum

188

624

1.90

14.22

1.4

1.7

3838.00

3625.37

titre

0.13

123

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

597

2651

1.43

14.19

1.2

1.1

—

(3008295) Osmolality of Serum or Plasma

510

2200

1.47

14.13

1.4

1.3

277.67

277.12

mosm/kgh2o

0.18

405

1662

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

957

4597

1.32

13.98

1.3

1.2

5.15

4.90

u/ml

0.03

285

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

184

613

1.90

13.78

1.2

—

(36660697) Celiac disease serology panel - Serum

2705

14601

1.18

13.75

1.2

—

(3000330) Specific gravity of Urine by Test strip

1928

10091

1.22

13.72

3.9

3.3

1.02

ratio

0.29

1743

9103

(3033705) Calcium.ionized [Moles/volume] in Venous blood

478

2052

1.47

13.59

3.0

2.1

1.20

mmol/l

0.21

473

2039

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

229

822

1.76

13.55

1.7

1.8

85.02

115.68

umol/l

1.50

122

413

(4024509) Urine culture

1800

9377

1.22

13.43

2.2

1.9

—

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

359

1454

1.56

13.39

1.2

156.07

179.26

titre

0.23

230

(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay

443

1879

1.49

13.37

1.2

1.1

95.47

99.44

2.21

426

1727

(3046294) Neutrophil cytoplasmic Ab.classic [Titer] in Serum

358

1451

1.56

13.32

1.2

102.50

175.09

titre

—

(3024891) Influenza virus A+B Ag [Presence] in Specimen

895

4298

1.32

13.13

1.2

1.1

—

(3011544) Albumin [Mass/volume] in Pleural fluid

181

2.69

13.06

1.1

1.2

14.57

18.65

g/l

4.46

160

(4146454) Self-monitoring of blood glucose

552

2455

1.42

13.06

3.0

2.7

—

(3023091) Interleukin 6 [Mass/volume] in Serum or Plasma

261

2.37

12.96

1.4

1.2

102.75

440.21

ng/l

0.57

177

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

567

2539

1.41

12.92

1.2

1.1

—

(3020191) Ethanol [Moles/volume] in Serum or Plasma

395

1648

1.52

12.92

1.5

1.28

1.33

promille

0.23

312

1318

(3016724) Homocysteine [Moles/volume] in Serum or Plasma

321

1278

1.59

12.90

1.6

1.4

15.40

12.96

umol/l

5.52

299

1200

(1617658) Protocol used for examination of sentinel lymph nodes

132

1608

0.52

12.86

1.1

1.0

—

(40758047) Lysozyme [Mass/volume] in Pleural fluid

148

2.86

12.72

1.2

1.1

9.28

10.43

mg/l

0.33

138

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

399

1674

1.51

12.72

1.2

—

(3022621) pH of Urine by Test strip

2879

15719

1.17

12.70

3.1

2.6

6.01

6.04

1.09

2086

10553

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

142

445

2.02

12.69

1.2

—

(3000475) Leukocytes [#/volume] in Synovial fluid

1100

5463

1.28

12.56

1.6

13871.20

13312.65

e6/l

0.14

784

3805

(3035947) Staphylolysin Ab [Units/volume] in Serum

244

914

1.69

12.47

1.2

1.1

5.17

3.61

iu/ml

0.43

(3012898) Urea [Moles/volume] in Urine

175

2.67

12.44

1.4

1.3

139.32

178.10

mmol/l

2.11

155

(3050099) BK virus DNA [#/volume] (viral load) in Specimen by NAA with probe detection

4.42

12.27

3.7

3.8

—

(40762365) Oxygen content in Arterial blood by calculation

101

280

2.28

12.25

2.8

3.4

15.47

14.53

ml/dl

2.45

267

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

459

1997

1.45

12.25

3.5

3.8

—

(3029634) Reagin Ab [Titer] in Serum by VDRL

523

2334

1.42

12.18

2.2

2.5

7.18

7.03

titre

0.01

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

136

427

2.01

12.12

1.1

79.40

88.44

2.38

205

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

1079

5373

1.27

12.07

1.3

6.31

5.15

u/ml

0.25

102

485

(3011547) Coagulation factor VII activity actual/normal in Platelet poor plasma by Coagulation assay

136

429

2.00

11.98

1.2

100.00

106.95

1.08

126

399

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

1077

5369

1.27

11.95

1.3

6.36

6.78

u/ml

0.11

156

781

(3050129) First trimester maternal screen panel - Serum or Plasma

586

0.25

11.80

1.7

1.4

—

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

132

415

2.01

11.74

1.1

1.2

78.63

89.29

2.01

200

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

550

2493

1.40

11.74

1.1

—

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

1140

5736

1.26

11.72

1.3

46.26

41.20

u/ml

0.21

290

(3003985) Beta hydroxybutyrate [Moles/volume] in Serum or Plasma

159

2.70

11.70

1.6

2.3

1.13

1.01

mmol/l

0.17

101

(3002079) Sodium [Moles/time] in 24 hour Urine

221

821

1.70

11.68

1.2

165.28

163.86

mmol/24h

0.07

221

821

(3043870) Heparin induced platelet Ab [Units/volume] in Serum

152

2.74

11.67

1.2

1.1

0.13

0.41

u/ml

0.63

(3001850) Coagulation factor XI activity actual/normal in Platelet poor plasma by Coagulation assay

275

2.25

11.59

1.3

1.2

91.32

86.11

0.37

(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma

321

1313

1.55

11.55

1.3

98.43

90.33

u/l

0.62

273

1120

(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma

314

1280

1.55

11.47

1.3

1.2

32.41

25.54

u/l

0.99

259

1070

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

479

0.18

11.44

1.6

1.4

1.11

0.96

ratio

—

293

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

479

0.18

11.44

1.6

1.4

0.87

1.16

ratio

—

293

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

479

0.18

11.44

1.6

1.4

1.27

1.21

ratio

—

294

(3020491) Glucose [Moles/volume] in Blood

315

1286

1.55

11.43

2.0

1.8

7.71

7.12

mmol/l

2.29

221

883

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

324

1335

1.53

11.29

1.4

—

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

473

0.19

11.24

1.6

1.4

—

(3006922) Hepatitis E virus Ab [Presence] in Serum

353

1486

1.50

11.15

1.1

—

(3047189) Immunofixation for 24 hour Urine

251

979

1.62

11.05

1.7

1.9

—

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

1101

0.46

11.02

1.1

—

(3033670) Parathyrin related protein [Moles/volume] in Serum or Plasma

146

488

1.89

10.95

1.2

15.87

10.80

pmol/l

1.11

168

(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma

270

1076

1.59

10.90

1.6

1.4

7.70

5.78

u/l

1.29

235

923

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

832

4065

1.30

10.85

1.3

1.2

49.60

47.44

u/ml

0.13

361

(3026692) Albumin [Mass/volume] in Peritoneal fluid

163

567

1.82

10.81

1.4

1.3

16.52

12.05

g/l

7.69

126

421

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

3921

22139

1.13

10.66

1.9

1.8

1.61

1.50

11.08

3336

19284

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

209

786

1.68

10.61

1.1

1603.40

1515.21

miu/ml

0.54

209

786

(42529582) MDA5 Ab [Presence] in Serum by Line blot

145

489

1.87

10.60

1.1

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

145

489

1.87

10.60

1.1

—

(3013637) Mi-2 Ab [Presence] in Serum

145

489

1.87

10.60

1.1

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

145

489

1.87

10.60

1.1

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

441

3874

0.71

10.59

1.6

2.1

—

(3043238) Trisomy 21 risk [Likelihood] in Fetus

420

0.16

10.57

1.5

—

(3026051) Granulocytes/Leukocytes in Pleural fluid

134

441

1.92

10.54

1.4

26.31

22.10

0.85

108

374

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

315

1314

1.52

10.42

1.4

—

(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma

282

1149

1.55

10.38

1.1

105.05

81.40

u/l

2.62

255

1017

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

303

1256

1.53

10.33

1.1

—

0.49

—

(3040491) Angiotensin converting enzyme [Enzymatic activity/volume] in Pleural fluid

186

2.44

10.25

1.2

1.1

17.12

21.25

u/l

1.29

126

(3052592) Norovirus Ag [Presence] in Stool

104

316

2.08

10.19

1.4

1.2

—

(3002348) Coagulation factor XII activity actual/normal in Platelet poor plasma by Coagulation assay

279

2.15

10.14

1.3

1.2

78.78

77.66

0.07

(3010144) Erythrocytes [#/volume] in Synovial fluid

435

1950

1.41

9.98

1.3

1.4

140989.94

119239.59

e6/l

0.22

281

1275

(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma

278

1142

1.54

9.89

1.2

1.1

36.87

22.26

u/l

2.21

251

1008

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

115

368

1.97

9.83

1.2

—

(3013139) Helicobacter pylori Ag [Presence] in Stool

2386

13107

1.16

9.71

1.2

1.3

—

(3034426) Prothrombin time (PT)

141

488

1.82

9.57

1.3

1.2

28.21

27.87

0.27

141

488

(3003327) Ova and parasites identified in Stool by Light microscopy

1201

6221

1.22

9.56

1.6

1.7

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

367

3264

0.71

9.54

1.6

2.1

—

(3034459) Mononuclear cells/Leukocytes in Pleural fluid

201

2.32

9.50

1.4

72.63

72.62

0.00

167

(3028371) Actinomyces sp identified in Specimen by Organism specific culture

209

2.29

9.49

1.1

—

(3044007) Cell count panel - Peritoneal fluid

185

699

1.67

9.30

2.1

1.8

—

(3023487) Leukocytes [#/volume] in Peritoneal fluid

213

838

1.61

9.16

2.2

1.8

3146.55

1600.81

e6/l

0.29

148

539

(3016628) Fibrinogen Ag [Mass/volume] in Platelet poor plasma by Immunoassay

107

343

1.97

9.14

1.2

52.81

32.01

mg/l

0.15

247

(46236287) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Pleural fluid by Immunoassay

3.15

9.05

1.2

1.1

8691.00

1896.67

ng/l

1.92

(40768800) Prostate Pathology biopsy report

654

5299

0.77

9.05

1.2

—

(43055458) Rivaroxaban [Mass/volume] in Serum or Plasma

155

2.48

9.04

1.2

82.85

114.91

ug/l

1.17

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

574

2752

1.32

8.69

1.6

1.5

—

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

230

2.17

8.68

2.5

1.3

—

(3001501) Glucose [Moles/volume] in Capillary blood by Glucometer

110

365

1.90

8.54

2.7

2.2

7.75

7.30

mmol/l

0.59

238

(3039443) Prostate specific Ag panel - Serum or Plasma

599

4870

0.77

8.54

1.7

—

20.32

—

(3008832) Norclozapine [Moles/volume] in Serum or Plasma

1041

0.52

8.41

9.5

14.7

778.05

2103.26

nmol/l

0.54

997

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

3844

26659

0.90

8.41

6.5

5.0

33.74

31.89

20.21

2945

16518

(40757373) Influenza virus identified in Isolate

310

1.97

8.40

1.7

1.4

—

(3018658) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum

173

662

1.65

8.35

1.2

1.1

5.17

11.20

u/ml

0.47

(3012215) Mononuclear cells/Leukocytes in Synovial fluid

133

473

1.78

8.33

1.2

1.3

39.41

39.69

0.02

311

(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma

603

2931

1.30

8.29

1.9

2.0

26.37

26.94

ug/l

0.06

589

2876

(3030558) Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection

181

708

1.61

8.03

1.9

1.6

64582.03

17205.93

u/ml

0.53

101

(3037692) Legionella sp identified in Specimen by Organism specific culture

170

657

1.63

7.92

1.7

1.2

—

(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma

340

1524

1.41

7.92

1.0

1.1

288.36

286.31

mg/l

0.20

311

1373

(4035726) Immunohistochemistry procedure

2850

20033

0.89

7.91

1.5

1.4

—

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

171

663

1.63

7.87

1.2

—

(3035320) C reactive protein [Mass/volume] in Body fluid

340

1527

1.41

7.84

3.1

2.6

30.59

29.94

mg/l

0.10

248

1089

(3004809) Band form neutrophils/Leukocytes in Blood

729

3659

1.26

7.81

3.5

3.6

1.37

1.67

1.28

658

3258

(3049714) Procollagen type I.N-terminal propeptide [Mass/volume] in Serum

181

714

1.60

7.78

2.2

1.9

62.85

59.06

ug/l

0.26

176

697

(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma

475

3925

0.76

7.71

1.4

202.40

177.85

pmol/l

0.32

463

3831

(3028300) Cannabinoids [Presence] in Urine

498

4086

0.76

7.67

2.1

1.9

—

(3006571) Granulocytes/Leukocytes in Synovial fluid

515

2479

1.31

7.65

1.5

60.34

57.62

0.80

342

1535

(3027944) Amphetamines [Presence] in Urine

486

3995

0.76

7.59

2.2

1.8

—

(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma

126

455

1.75

7.55

1.1

1.50

2.92

u/ml

—

(42868691) Thyroxine (T4) free [Moles/volume] in Serum or Plasma by Dialysis

149

564

1.67

7.54

1.3

1.5

15.05

14.99

pmol/l

0.04

128

465

(3043410) Blood group antigens tested for on Red Blood Cells

130

474

1.73

7.53

1.9

—

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

446

2108

1.34

7.52

1.1

—

(3027008) Opiates [Presence] in Urine

497

4068

0.77

7.52

2.1

1.8

—

(3000764) Benzodiazepines [Presence] in Urine

496

4052

0.77

7.40

2.1

1.9

—

(3044416) Complement C4 [Mass/volume] in Pleural fluid

2.95

7.38

1.2

1.3

0.06

0.08

g/l

0.78

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

180

1738

0.65

7.36

1.4

1.3

164.69

175.88

pmol/l

0.59

180

1738

(3003329) Lymphocytes/Leukocytes in Synovial fluid

392

1825

1.36

7.31

1.5

24.55

31.52

3.79

259

1087

(3023383) Lactate [Moles/volume] in Pleural fluid

160

629

1.61

7.03

1.4

1.3

3.22

3.74

mmol/l

1.35

143

584

(3016879) Cocaine [Presence] in Urine

469

3827

0.77

6.97

2.1

1.9

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

233

999

1.47

6.94

1.3

1.5

—

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

264

1160

1.44

6.93

1.2

—

(3000213) Normetanephrine [Moles/time] in 24 hour Urine

164

2.23

6.92

1.1

2.01

1.66

umol/24h

1.13

164

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

233

1000

1.47

6.91

1.3

1.5

—

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

946

4953

1.21

6.89

1.8

1.9

12.76

14.20

iu/l

0.05

333

1868

(3005791) Eosinophil cationic protein (ECP) [Mass/volume] in Serum

162

643

1.59

6.85

2.0

1.7

21.58

414.70

ug/l

1.62

153

615

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

282

1257

1.42

6.85

1.5

1.6

9.42

6.19

u/l

2.00

216

1003

(3025130) Human papilloma virus identified in Specimen

219

2003

0.69

6.82

1.7

—

(3000285) Sodium [Moles/volume] in Blood

103

362

1.80

6.80

1.3

138.47

138.22

mmol/l

0.23

306

(3009613) Erythrocytes [#/volume] in Peritoneal fluid

179

729

1.55

6.79

1.9

1.7

16783.87

8266.47

e6/l

0.80

364

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

872

0.53

6.73

1.6

1.5

1042.84

1061.27

mu/l

0.05

691

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

260

1148

1.43

6.67

1.2

—

(3013201) Beta-2-Microglobulin [Mass/volume] in Serum or Plasma

371

1740

1.35

6.65

1.8

1.9

4.40

3.83

mg/l

1.33

355

1677

(3013166) Neutrophils/Leukocytes in Synovial fluid

137

526

1.64

6.63

1.3

1.4

67.84

53.99

4.49

111

451

(3018851) Theophylline [Moles/volume] in Serum or Plasma

151

2.26

6.63

1.5

1.6

51.37

45.41

umol/l

0.55

151

(3002331) Protein [Mass/volume] in Peritoneal fluid

138

531

1.64

6.63

1.5

1.3

28.69

39.65

g/l

0.43

114

382

(44786800) Granulocytes/Leukocytes in Body fluid

222

2.02

6.62

1.3

1.4

21.44

27.11

0.69

182

(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum

321

1.83

6.52

1.1

11.40

20.88

u/ml

—

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

221

952

1.47

6.46

2.4

2.3

—

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

210

898

1.48

6.38

1.2

1.1

1.07

ratio

0.11

178

735

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

332

1554

1.35

6.07

2.0

8.53

2.12

u/field

0.45

187

851

(21494434) Karyotype in Bone marrow

396

1905

1.31

6.02

1.2

—

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

223

980

1.44

5.92

2.0

1.8

2.33

2.37

u/field

0.03

168

703

(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection

334

1.76

5.79

1.1

1.2

17613.33

230608.97

u/ml

—

(40759850) Jo-1 extractable nuclear Ab [Presence] in Serum by Immunoblot

327

1542

1.34

5.73

1.2

—

(1001926) Buprenorphine [Presence] in Urine by Screen method

386

3131

0.77

5.57

2.3

1.9

—

(3027035) Albumin [Mass/time] in 24 hour Urine

172

2.05

5.54

1.1

1.4

394.16

230.60

mg/24h

—

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

486

3828

0.80

5.49

1.5

—

(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay

2.62

5.41

1.2

1.1

—

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

193

841

1.45

5.41

1.1

1.0

—

(3019832) Treponema pallidum Ab [Presence] in Serum

1354

7462

1.15

5.40

1.7

1.6

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

361

1748

1.30

5.30

1.2

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

319

1523

1.32

5.19

1.2

—

(3032390) JC virus DNA [#/volume] (viral load) in Urine by NAA with probe detection

3.66

5.14

1.1

1.2

—

(3036669) Protein S actual/normal in Platelet poor plasma by Coagulation assay

151

634

1.50

5.11

1.1

1.0

95.42

100.67

1.38

115

512

(3045424) Erythrocytes [Presence] in Urine

1816

10246

1.12

5.06

2.5

2.1

0.11

0.10

estimate

0.01

541

2902

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

302

1437

1.33

5.04

1.2

—

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

328

1583

1.31

4.96

1.7

2.1

1417.74

3621.51

u/l

1.44

559

(40762119) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum

553

2844

1.23

4.94

1.2

15.42

13.54

u/ml

0.06

106

(3002256) Pathology report gross observation

4187

28252

0.93

4.94

1.3

—

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

339

1645

1.30

4.93

1.6

25.52

25.63

u/ml

0.01

327

(3020911) Cortisol [Moles/time] in 24 hour Urine

142

594

1.51

4.91

1.5

1.4

78.43

294.16

nmol/24h

2.10

142

594

(3010838) Calcium [Moles/time] in 24 hour Urine

712

3757

1.20

4.91

1.8

1.9

4.24

5.25

mmol/24h

12.94

632

3312

(21491866) Provasopressin.C-terminal [Moles/volume] in Serum or Plasma by Immunoassay

159

2.02

4.90

1.3

1.2

13.64

17.13

pmol/l

0.36

136

(3023323) Follitropin [Units/volume] in Serum or Plasma

605

4598

0.83

4.88

1.4

29.26

35.15

iu/l

3.65

501

3889

(40766800) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ T-cells [Units/volume] corrected for background in Blood

388

1920

1.28

4.86

1.1

1.71

2.17

iu/ml

—

(3018333) Ribosomal P Ab [Presence] in Serum

296

1414

1.32

4.83

1.2

—

(40760543) Extractable nuclear Ab [Presence] in Serum by Immunoblot

200

898

1.41

4.82

1.2

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

309

1492

1.31

4.69

1.2

—

(3003101) Alpha 1 antitrypsin [Mass/mass] in Stool

2.54

4.66

1.3

1.1

173.39

184.51

ug/g

0.12

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

309

1493

1.31

4.66

1.2

—

(3042552) Rheumatoid factor [Units/volume] in Pleural fluid

146

2.03

4.58

1.1

20.21

16.82

iu/ml

0.11

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

314

1526

1.30

4.55

1.2

90.38

110.78

pmol/l

11.00

314

1526

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

164

1.96

4.54

1.3

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

302

1462

1.30

4.51

1.2

—

(3034274) Bile acid [Moles/volume] in Serum --fasting

189

851

1.40

4.51

1.4

1.6

14.58

12.79

umol/l

0.16

121

631

(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum

242

1135

1.35

4.50

1.1

10.87

6.95

nmol/l

0.52

225

(3040370) OLANZapine [Moles/volume] in Serum or Plasma

712

0.59

4.36

2.9

2.7

119.82

150.02

nmol/l

1.86

622

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

227

1062

1.35

4.31

1.3

1.1

—

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

197

902

1.38

4.28

4.0

3.1

1.37

1.30

0.18

197

902

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

208

963

1.36

4.23

1.4

1.5

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

208

963

1.36

4.23

1.4

1.5

—

(3001964) Herpes simplex virus Ag [Presence] in Specimen

114

472

1.52

4.20

1.8

1.3

—

(3006270) Folate [Moles/volume] in Blood

305

1497

1.29

4.15

1.2

358.90

358.47

nmol/l

0.01

244

1270

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

430

2199

1.24

4.13

1.2

—

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

821

4456

1.17

4.13

1.2

1.1

2.58

3.40

1.87

560

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

498

2587

1.22

4.12

2.3

2.0

25.72

27.37

mg/l

0.28

198

929

(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence

293

1433

1.29

4.10

1.3

442.78

559.02

titre

0.15

102

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

838

6095

0.86

4.06

2.0

1.5

6.32

3.78

mg/l

3.40

686

4540

(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum

422

2159

1.23

4.05

1.2

47.56

43.18

u/ml

0.12

103

(4281824) Cell count and differential, peritoneal fluid

302

2414

0.79

4.01

1.2

1.1

—

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

507

2650

1.21

3.96

1.4

—

(3019897) Erythrocyte [DistWidth] in Red Blood Cells by Automated count

231

1906

0.76

3.95

4.6

2.8

13.46

13.25

1.99

225

1877

(3025468) Yersinia sp identified in Specimen by Organism specific culture

485

2525

1.21

3.94

1.4

—

(40765955) DNA double strand Ab [Titer] in Pleural fluid by Immunofluorescence

6.30

3.94

1.1

—

(3024522) Salmonella sp identified in Specimen by Organism specific culture

508

2657

1.21

3.94

1.4

—

(40761539) Cells [Type] in Urine sediment by Light microscopy

109

455

1.51

3.90

1.3

1.2

—

(40761545) Erythrocytes.dysmorphic [Presence] in Urine sediment by Light microscopy

113

2.07

3.83

1.1

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

1329

9335

0.89

3.77

1.6

1.8

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

484

2532

1.21

3.77

1.4

—

(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection

2.15

3.75

5.6

4.0

—

(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection

2.33

3.71

1.2

1.1

—

(3005988) Vibrio sp identified in Specimen by Organism specific culture

484

2537

1.21

3.70

1.4

—

(3024666) Lithium [Moles/volume] in Serum or Plasma

104

963

0.68

3.69

14.1

13.7

0.64

mmol/l

0.02

884

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

515

2717

1.20

3.68

1.4

—

(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method

151

1.88

3.62

1.4

1.5

—

(1175426) CD3 cells/Lymphocytes in Blood

279

1381

1.28

3.61

1.8

2.1

72.39

71.70

0.29

262

1320

(3045066) Thymidine kinase [Enzymatic activity/volume] in Serum

128

562

1.44

3.60

1.8

2.0

33.28

46.61

u/l

0.38

117

517

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

761

0.65

3.60

1.1

1.2

—

(3011412) CD3 cells [#/volume] in Blood

349

1776

1.24

3.57

2.0

2.5

996.33

1183.84

e6/l

2.20

304

1593

(3028433) Virus identified in Specimen by Culture

135

600

1.42

3.56

1.2

—

(3011288) Drugs identified in Urine by Screen method Nominal

339

2623

0.81

3.42

2.4

2.8

—

(3001686) Cold agglutinin [Titer] in Serum or Plasma

347

1.55

3.42

1.2

1.4

387.67

287.47

titre

—

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

135

606

1.41

3.39

2.0

2.1

2.06

1.67

ratio

1.52

130

585

(3020618) Glucose [Moles/volume] in Synovial fluid

2.38

3.32

1.0

1.1

6.14

4.89

mmol/l

0.61

(3002621) Streptococcal DNAse B [Units/volume] in Serum

147

1.84

3.30

1.1

1.0

241.77

326.32

u/ml

0.55

(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence

280

1405

1.26

3.28

1.3

122.94

64.74

titre

0.36

(44813793) Dust mix specific IgE antibody measurement

236

1162

1.28

3.23

1.0

1.1

—

(40766799) MGMT gene methylation score in Tissue by Molecular genetics method

186

0.34

3.16

1.0

—

(4015189) Microbial culture of sputum

120

535

1.42

3.16

2.2

—

(3020717) Zinc [Moles/volume] in Serum or Plasma

204

989

1.30

3.15

1.4

1.5

18.28

23.55

umol/l

2.22

186

912

(3007821) Glucose [Moles/volume] in Serum or Plasma --baseline

166

782

1.34

3.14

1.3

6.07

6.11

mmol/l

0.20

152

744

(37208534) Antinuclear antibody arbitrary concentration in serum

135

616

1.38

3.12

1.1

—

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

345

1.52

3.11

1.6

1.5

—

(4211845) Urine protein measurement

195

943

1.31

3.08

3.1

3.2

—

(46234826) Other cells/Leukocytes in Peritoneal fluid by Manual count

128

1.87

3.07

2.0

1.9

16.60

21.74

0.37

(3006462) Nitrate [Presence] in Urine

181

867

1.32

3.06

3.1

3.3

—

(3041082) Glomerular basement membrane Ab [Titer] in Serum by Immunofluorescence

2.08

3.00

1.0

1.1

—

362.00

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

1223

8508

0.90

2.97

1.5

1.8

—

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

259

1.58

2.95

1.0

1.1

—

(43055459) Dabigatran [Mass/volume] in Serum or Plasma

2.32

2.91

1.4

100.15

112.19

ug/l

0.16

(3036670) Protein [Mass/volume] in Synovial fluid

137

635

1.36

2.91

1.2

1.3

40.71

40.31

g/l

0.10

329

(21491868) Cryoglobulin [Mass/volume] in Serum

146

684

1.35

2.89

1.3

1.2

0.37

0.69

g/l

0.45

(3009214) Lutropin [Units/volume] in Serum or Plasma

745

4133

1.14

2.89

1.4

10.11

10.05

u/l

0.04

598

3312

(3036603) Volume of Urine

314

1622

1.22

2.88

1.6

1830.83

1937.76

1.45

300

1584

(3042391) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method

127

1.84

2.85

4.1

6.1

—

(3046861) Legionella sp Ag [Presence] in Urine

109

1.91

2.84

1.1

—

(3027831) CD3-CD16+CD56+ (Natural killer) cells/cells in Blood

260

1319

1.24

2.83

1.8

2.1

15.70

16.45

0.50

250

1276

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

118

537

1.39

2.81

1.7

1.6

9.66

9.44

ug/l

0.20

118

537

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

104

463

1.42

2.81

2.2

2.7

333.62

446.13

ug/l

0.12

104

463

(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid

133

618

1.36

2.79

1.3

129.33

326.48

ug/l

1.18

356

(3032057) Clostridioides difficile [Presence] in Stool

417

1.44

2.77

1.8

—

(3004437) Lymphocytes/Leukocytes in Peritoneal fluid

161

1.72

2.77

2.5

1.9

67.54

59.20

0.85

(3047185) IgG [Mass/volume] in Urine

2.59

2.75

1.0

1.1

—

41.97

—

(3050794) Legionella sp Ab [Presence] in Serum

171

1.70

2.74

1.1

—

(3009347) Lactate dehydrogenase isoenzymes [Interpretation] in Serum or Plasma

1.97

2.72

1.1

1.0

—

(3010503) CD19 cells [#/volume] in Blood

235

1188

1.25

2.66

2.2

2.7

224.00

358.96

e6/l

0.52

224

1154

(42868452) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Bone marrow by Molecular genetics method

4.59

2.64

1.1

2.6

—

(3018133) Calcium [Moles/volume] in Urine

328

1.48

2.63

1.5

2.47

2.78

mmol/l

0.64

295

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

257

1.55

2.63

1.0

1.1

—

(3015302) Jo-1 extractable nuclear Ab [Units/volume] in Serum

247

1.56

2.63

1.6

1.5

—

(3015076) Soybean IgE Ab [Units/volume] in Serum

723

0.70

2.61

1.1

1.0

0.45

0.73

u/ml

0.25

175

(3010726) Horse dander IgE Ab [Units/volume] in Serum

298

2261

0.83

2.57

1.1

1.40

1.13

u/ml

0.36

144

1103

(3041678) Intrinsic coagulation system thromboelastography panel - Blood

151

1.71

2.55

1.6

1.4

—

(3007463) Buprenorphine [Presence] in Urine

3.50

2.54

10.7

8.1

—

(3016426) Methylmalonate [Moles/volume] in Serum or Plasma

2.05

2.52

1.1

243.92

293.87

nmol/l

0.76

(3003740) Influenza virus B Ag [Presence] in Specimen

362

2694

0.85

2.51

1.1

—

(3010370) Gastrin [Moles/volume] in Serum or Plasma

311

1.48

2.51

1.7

1.8

67.46

52.99

pmol/l

0.35

260

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

221

1723

0.81

2.51

1.0

0.58

0.39

u/ml

0.17

586

(3051252) Vasoactive intestinal peptide [Moles/volume] in Serum or Plasma

133

1.75

2.50

1.7

1.4

13.76

17.30

pmol/l

0.63

114

(3002523) Influenza virus A Ag [Presence] in Specimen

362

2691

0.85

2.48

1.1

—

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

211

1651

0.80

2.48

4.9

5.9

139.40

108.95

u/ml

0.16

522

(21494567) Legionella sp IgM Ab [Presence] in Serum

143

1.72

2.47

1.1

—

0.34

—

(3008757) Leukocyte morphology finding [Identifier] in Blood

414

2239

1.17

2.36

3.9

3.8

—

(21494814) CD8 cells/Lymphocytes in Specimen

157

769

1.29

2.35

1.9

2.1

28.79

32.49

2.24

157

769

(3016228) CD19 cells/cells in Blood

153

747

1.29

2.35

2.0

2.1

8.65

8.15

0.18

147

730

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

302

1591

1.20

2.34

1.0

1.1

—

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

199

1553

0.81

2.31

1.5

1.4

0.20

0.23

nmol/l

0.78

128

1064

(3029075) Extractable nuclear Ab panel - Serum

232

1193

1.23

2.31

1.1

—

0.29

—

(40768795) Lymph node Pathology biopsy report

310

2317

0.84

2.30

1.2

1.3

—

(3004280) Aldosterone [Moles/volume] in Serum or Plasma --supine

2.10

2.26

1.1

1.0

74.71

142.69

pmol/l

—

(3003888) Timothy IgE Ab [Units/volume] in Serum

341

2524

0.85

2.26

1.1

2.86

3.18

u/ml

0.20

160

1253

(3002619) Bacteria identified in Specimen by Culture

115

544

1.33

2.23

1.4

1.3

—

(3008401) Mugwort IgE Ab [Units/volume] in Serum

329

2439

0.85

2.23

1.1

1.01

1.02

u/ml

0.00

129

1033

(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma

134

1.69

2.20

1.2

1.1

11.64

10.91

u/l

0.09

134

(3014326) Insulin-like growth factor-I [Moles/volume] in Serum or Plasma

249

1299

1.21

2.17

1.7

2.2

16.05

16.31

nmol/l

0.22

233

1202

(3004616) Nuclear Ab [Presence] in Serum

460

2527

1.15

2.16

1.3

—

(3040668) CNBP gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

2.10

2.16

1.1

1.0

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

213

1096

1.23

2.13

1.8

1.9

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

213

1096

1.23

2.13

1.8

1.9

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

213

1096

1.23

2.13

1.8

1.9

—

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

123

592

1.31

2.13

1.1

—

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

141

1131

0.78

2.12

1.4

1.6

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

213

1097

1.23

2.12

1.8

1.9

—

(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma

266

1.47

2.12

1.4

1.7

1.60

0.98

nmol/l

—

(3023410) Appearance of Cerebral spinal fluid

281

2099

0.84

2.11

1.4

1.5

—

(3024263) Appearance of Synovial fluid

207

1064

1.23

2.10

1.6

1.7

—

(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum

113

1.73

2.05

1.1

1.94

1.64

iu/ml

0.35

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

749

4259

1.11

2.04

1.1

12.26

7.20

eliau/ml

0.59

476

(3023659) Complement C1 esterase inhibitor.functional/Complement C1 esterase inhibitor.total in Serum or Plasma

116

558

1.31

2.04

1.3

113.09

112.10

0.13

104

510

(3004347) Hepatitis D virus Ab [Presence] in Serum

2.19

2.02

1.1

1.0

—

(3023430) Cat dander IgE Ab [Units/volume] in Serum

253

1898

0.84

2.01

1.1

2.72

3.04

u/ml

0.16

106

812

(3035082) Kappa light chains [Mass/volume] in Urine

2.06

1.97

1.1

0.03

0.18

g/l

—

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

383

2093

1.16

1.97

1.2

7.66

7.60

mmol/l

0.14

337

1796

(3003191) Choriogonadotropin [Presence] in Serum or Plasma

111

907

0.77

1.96

1.4

1.6

—

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

409

1.36

1.96

1.2

—

(3019768) Coxiella burnetii Ab [Presence] in Serum

1.77

1.95

1.3

1.1

—

(40768443) Skin Pathology biopsy report

1653

9752

1.07

1.95

1.2

—

(3009876) Amylase isoenzyme 3 panel - Serum or Plasma

154

1.60

1.94

1.2

—

(3016913) Creatine kinase.MM [Enzymatic activity/volume] in Serum or Plasma by Electrophoresis

1.86

1.92

1.2

1.1

237.94

502.55

u/l

0.87

(3014599) Egg white IgE Ab [Units/volume] in Serum

803

0.76

1.91

1.1

1.0

2.62

1.01

u/ml

0.44

189

(3024869) Neuronal Ab [Presence] in Serum

406

1.35

1.90

1.1

—

(3019174) dRVVT (LA screen)

126

1.65

1.88

1.2

—

(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma

120

588

1.29

1.87

1.4

1.3

0.32

0.31

g/l

0.62

480

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

429

1.34

1.86

1.1

—

(3033306) Mononuclear cells/Leukocytes in Cerebral spinal fluid

177

909

1.23

1.86

1.2

62.60

58.87

0.18

104

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

601

3398

1.12

1.85

1.3

151.27

204.31

miu/ml

2.51

133

1376

(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)

296

1.41

1.83

1.4

1.2

—

(3014037) CD3+CD4+ (T4 helper) cells/cells in Blood

229

1209

1.20

1.82

2.5

2.8

39.03

37.36

0.66

145

614

(40762887) Creatinine [Moles/volume] in Blood

147

1.59

1.82

1.2

1.4

—

(37019676) Renin [Units/volume] in Plasma --supine

2.21

1.81

1.0

84.65

19.00

mu/l

—

(46234834) Bacteria identified in Bone by Anaerobe+Aerobe culture

175

0.50

1.80

1.0

1.2

—

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

340

1.37

1.79

1.1

1100.00

843.06

titre

0.79

(3029536) Hepatitis C virus RNA [Units/volume] (viral load) in Specimen by NAA with probe detection

174

896

1.23

1.79

1.5

1.4

1811175.00

2110401.85

iu/ml

0.15

(3043681) Transitional cells [#/area] in Urine by Computer assisted method

1.72

1.78

1.1

1.00

1.04

u/field

0.18

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

155

1201

0.81

1.77

6.0

7.3

134.51

114.98

ug/l

0.07

774

(3001186) Copper [Moles/volume] in Serum or Plasma

101

488

1.31

1.76

1.2

15.98

16.44

umol/l

0.41

419

(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay

1.88

1.75

1.2

1.1

—

(3017354) Segmented neutrophils/Leukocytes in Blood

443

2470

1.13

1.74

3.4

3.6

60.49

57.13

2.77

385

2123

(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright

456

1.31

1.74

1.1

1.2

323.22

279.70

pmol/l

0.25

329

(3038026) Centromere Ab [Units/volume] in Serum

288

1558

1.17

1.74

1.2

29.24

59.69

u/ml

1.13

(3001729) Color of Synovial fluid

150

1.56

1.69

1.4

1.7

—

(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum

1.74

1.66

1.1

1.2

0.83

0.48

iu/ml

0.72

(3030862) Granulocytes [#/volume] in Cerebral spinal fluid

122

611

1.26

1.64

1.2

25.05

24.89

0.01

(3008536) Aspergillus sp Ab [Presence] in Serum

439

1.31

1.63

1.7

2.2

—

(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma

467

0.71

1.62

2.3

2.1

2.47

9.07

ug/l

1.54

251

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

452

0.71

1.62

1.4

2.2

—

(3016284) Epstein Barr virus nuclear Ab [Units/volume] in Serum

2.42

1.61

1.4

1.1

253.59

297.38

u/ml

—

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

425

2379

1.13

1.60

1.1

3.04

2.65

0.26

349

(3014133) Dog dander IgE Ab [Units/volume] in Serum

275

2003

0.86

1.59

1.1

4.37

2.93

u/ml

0.83

141

963

(3018980) carBAMazepine [Moles/volume] in Serum or Plasma

144

740

1.23

1.56

3.1

3.2

29.39

28.26

umol/l

0.55

105

575

(3043138) Epithelial cells.renal [#/area] in Urine by Computer assisted method

1.86

1.54

1.0

1.1

1.17

1.36

u/field

0.14

(3034891) Synovial lining cells/cells in Synovial fluid

183

966

1.20

1.52

1.5

1.4

3.34

4.28

0.46

192

(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification

156

1185

0.83

1.51

4.8

6.4

1784.94

3487.72

u/ml

0.22

225

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

417

2942

0.89

1.49

1.1

2.30

1.57

u/ml

0.61

231

1571

(3027974) Hepatitis B virus e Ag [Presence] in Serum

110

1.60

1.48

1.5

1.7

—

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

227

1224

1.17

1.48

1.9

2.6

459.34

568.67

e6/l

1.80

172

1010

(3039114) Acanthocytes/1000 erythrocytes in Blood by Light microscopy

2.47

1.48

1.3

1.1

0.33

1.35

—

(3006969) Lambda light chains [Mass/volume] in Urine

1.90

1.47

1.1

1.2

0.02

0.07

g/l

—

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

222

1631

0.86

1.47

1.3

31.62

34.91

u/l

0.74

180

1321

(3009015) Lactate [Moles/volume] in Synovial fluid

229

1.40

1.46

1.2

1.3

6.90

6.85

mmol/l

0.02

111

(3036604) Creatine kinase isoenzymes [Interpretation] in Serum or Plasma by Electrophoresis

121

1.56

1.44

1.3

1.1

—

(3014271) Vancomycin [Susceptibility]

196

1048

1.18

1.43

3.0

2.9

—

(3020564) Creatinine [Moles/volume] in Serum or Plasma

32086

203025

0.96

1.42

35.4

20.2

88.25

77.60

umol/l

251.45

31843

200444

(3041008) Bicarbonate [Moles/volume] standard in Arterial cord blood

1.67

1.41

1.8

1.4

25.56

23.67

mmol/l

0.75

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

454

0.74

1.40

2.0

1.8

—

(44786774) Adalimumab [Mass/volume] in Serum or Plasma

590

0.77

1.40

2.1

1.9

7.91

8.98

mg/l

1.10

484

(3025296) Carrot IgE Ab [Units/volume] in Serum

0.00

1.39

0.0

1.0

—

0.37

—

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

373

0.71

1.39

1.1

—

(3045142) Bone marrow Pathology biopsy report

454

2578

1.11

1.38

1.3

—

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

275

1.35

1.38

1.1

1.2

—

(3016273) Islet cell 512 Ab [Units/volume] in Serum

1.70

1.37

1.0

—

(44817194) Complement alternate pathway AH50 actual/normal in Serum by Immunoassay

286

1.35

1.37

1.4

1.3

94.97

99.78

0.81

281

(3019420) Tryptase [Mass/volume] in Serum or Plasma

183

977

1.18

1.37

1.6

10.75

8.39

ug/l

0.51

166

904

(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma

0.00

1.36

0.0

1.0

—

76.00

—

(40761995) Spermatozoa Progressive [#/volume] in Semen

158

0.56

1.35

3.5

3.0

43.00

42.25

0.04

158

(3041423) Sjogrens syndrome-A extractable nuclear 60kD Ab [Units/volume] in Serum

330

1843

1.13

1.35

1.2

50.91

89.76

u/ml

1.17

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

386

1.29

1.34

1.1

—

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

2101

13860

0.95

1.34

2.4

24.40

22.82

au/ml

0.27

131

1417

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

247

1354

1.15

1.33

1.3

1.80

1.48

u/ml

0.20

147

808

(3016244) Insulin [Units/volume] in Serum or Plasma

160

847

1.19

1.33

2.7

3.1

25.44

25.40

mu/l

0.00

151

792

(3014043) Spermatozoa Nonprogressive/Spermatozoa in Semen

157

0.56

1.33

7.0

6.0

7.50

8.64

0.35

157

(3045683) HLA typing for celiac disease panel - Blood or Tissue

167

888

1.19

1.32

1.0

—

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

1834

11008

1.05

1.32

1.2

122.12

139.38

u/ml

1.10

691

4007

(3020123) Porphyrins [Interpretation] in Serum or Plasma

1.61

1.31

1.0

1.2

—

(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood

230

1258

1.15

1.29

1.9

2.8

228.04

239.63

e6/l

0.28

192

1094

(3019779) Phenytoin [Moles/volume] in Serum or Plasma

257

1.35

1.28

3.6

3.4

43.43

41.72

umol/l

0.23

227

(3006245) CD3-CD19+ cells/cells in Blood

119

615

1.22

1.28

1.7

2.1

9.31

9.72

0.12

106

556

(3007449) CD3+CD8+ (T8 suppressor) cells/cells in Blood

121

627

1.22

1.27

1.6

2.1

31.60

30.59

0.25

111

586

(3042517) Benzodiazepines panel - Urine

105

1.56

1.26

5.8

2.4

—

(3009466) Valproate [Moles/volume] in Serum or Plasma

425

2959

0.90

1.25

4.6

5.4

341.06

360.02

umol/l

2.08

375

2561

(3021691) Plasmodium malariae Ab [Titer] in Serum

2.87

1.24

2.0

2.5

—

(3041806) Other cells [#/volume] in Blood by Manual count

0.47

1.24

1.9

1.5

0.49

e9/l

—

(3044291) Thermoactinomyces vulgaris IgG Ab [Mass/volume] in Serum

2.52

1.24

1.0

1.1

—

(36304052) Adalimumab Ab [Units/volume] in Serum or Plasma

451

0.75

1.24

1.7

1.6

68.01

92.89

au/ml

—

(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay

161

0.59

1.23

1.7

2.0

—

(36203821) Streptococcus pneumoniae Danish serotype 1 IgG Ab [Mass/volume] in Serum

1.59

1.22

1.6

1.5

0.90

2.10

mg/l

1.27

(3006044) Creatine kinase.total/Creatine kinase.MB [Enzymatic activity ratio] in Serum or Plasma

1.94

1.18

1.3

1.0

2.17

2.64

0.36

(40758355) Pancreatic polypeptide [Moles/volume] in Serum or Plasma

272

1.32

1.18

3.0

2.8

77.97

62.97

pmol/l

0.74

237

(3010015) Selenium [Moles/volume] in Serum or Plasma

159

1.43

1.18

1.5

1.7

1.49

1.32

umol/l

1.13

104

(3016616) Dehydroepiandrosterone sulfate (DHEA-S) [Moles/volume] in Serum or Plasma

110

570

1.22

1.17

1.4

1.3

2.16

3.52

umol/l

4.66

492

(3035611) Eosinophils/Leukocytes in Synovial fluid

128

1.48

1.16

1.4

1.8

1.10

0.61

0.46

101

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

169

912

1.17

1.16

2.1

38.52

40.20

g/l

3.00

169

912

(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma

150

802

1.18

1.15

2.1

2.4

59.12

52.54

umol/l

1.07

117

689

(3025059) Transferrin.carbohydrate deficient [Mass/volume] in Serum or Plasma

118

1.50

1.15

1.3

45.81

49.89

mg/l

—

(3015183) Erythrocyte sedimentation rate [Velocity] in Red Blood Cells

101

774

0.82

1.15

1.2

13.99

10.93

mm/h

1.28

101

774

(40765089) Chromosome analysis panel - Blood by G-banded

188

0.64

1.13

1.0

—

(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum

188

0.64

1.13

1.0

8.69

8.66

u/ml

0.00

188

(3000899) Streptococcus pneumoniae Danish serotype 7F IgG Ab [Mass/volume] in Serum

1.58

1.13

1.6

1.5

1.54

2.36

mg/l

0.47

(36204187) Streptococcus pneumoniae Danish serotype 4 IgG Ab [Mass/volume] in Serum

1.58

1.13

1.6

1.5

0.46

1.21

mg/l

0.97

(36204005) Streptococcus pneumoniae Danish serotype 19F IgG Ab [Mass/volume] in Serum

1.58

1.13

1.6

1.5

2.31

2.21

mg/l

0.03

(36204094) Streptococcus pneumoniae Danish serotype 23F IgG Ab [Mass/volume] in Serum

1.58

1.13

1.6

1.5

3.07

2.96

mg/l

0.02

(36203922) Streptococcus pneumoniae Danish serotype 14 IgG Ab [Mass/volume] in Serum

1.58

1.13

1.6

1.5

1.96

3.85

mg/l

1.37

(36204286) Streptococcus pneumoniae Danish serotype 5 IgG Ab [Mass/volume] in Serum

1.58

1.13

1.6

1.5

1.47

2.34

mg/l

0.50

(3005665) Streptococcus pneumoniae Danish serotype 6B IgG Ab [Mass/volume] in Serum

1.58

1.13

1.6

1.5

2.62

1.21

mg/l

0.40

(3038177) Helicobacter pylori Ab [Presence] in Serum

476

2744

1.09

1.13

1.3

1.2

—

(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid

123

921

0.84

1.10

1.1

467.00

440.00

ng/l

0.03

261

(42528595) U1 small nuclear ribonucleoprotein 70kD Ab [Presence] in Serum by Line blot

1.93

1.07

1.0

—

(3028707) Methadone [Presence] in Urine by Screen method

245

1740

0.89

1.07

2.7

2.5

—

(3017312) HC gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

131

0.58

1.07

1.1

—

(3044009) aPTT.lupus sensitive (LA screen)

131

1.44

1.06

1.3

1.2

—

(3034614) HLA Ag [Interpretation]

2.03

1.06

1.7

1.1

—

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

230

1281

1.13

1.05

2.5

1.7

—

(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture

221

0.68

1.03

1.5

2.1

—

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

237

1681

0.89

1.03

1.2

—

(3046904) Somatotropin [Units/volume] in Serum or Plasma

2.10

1.02

1.7

3.9

1.64

1.33

mu/l

—

(40764999) Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)/1.73 sq M

29647

186074

1.03

1.02

25.6

15.3

74.12

79.15

ml/min/173m2

314.05

28306

171905

(1761482) Bacteria [#/volume] in Urine by Culture

823

4872

1.07

1.02

4.8

3.9

—

(3009208) Meadow Fescue IgE Ab [Units/volume] in Serum

0.00

1.01

0.0

1.1

—

7.78

—

(3033099) Centromere Ab [Titer] in Serum

501

1.21

1.00

1.1

—

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

1941

12722

0.96

0.99

1.3

54.81

56.26

au/ml

0.09

879

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

441

0.79

0.98

1.6

1.5

—

(3003338) MCHC [Entitic Mass/volume] in Red Blood Cells

24810

155427

1.02

0.98

34.3

19.9

331.27

332.49

g/l

79.34

24671

154650

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

193

1.34

0.97

1.0

—

(1175310) Leucine-rich glioma-inactivated protein 1 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay

1.74

0.97

1.0

—

(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing

209

0.69

0.94

1.1

1.2

—

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

356

1.24

0.94

1.2

1.3

—

(42528596) U1 small nuclear ribonucleoprotein A Ab [Presence] in Serum by Line blot

1.76

0.92

1.0

—

(3014114) Aureobasidium pullulans IgG Ab [Mass/volume] in Serum

1.63

0.90

1.0

13.26

12.80

mg/l

—

(1175825) Sexually transmitted pathogens panel - Specimen by NAA with probe detection

1.85

0.89

1.1

1.0

—

(3014702) Chromogranin A [Moles/volume] in Serum or Plasma

441

2568

1.08

0.89

3.5

3.7

6.74

10.24

nmol/l

0.56

425

2502

(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal

108

0.58

0.89

1.6

1.5

—

(3045781) Inhibin B [Mass/volume] in Serum or Plasma

342

0.77

0.87

3.0

3.4

58.38

126.02

ng/l

1.62

107

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

254

1773

0.90

0.87

1.1

—

(3017446) Testosterone [Moles/volume] in Serum or Plasma

3091

20031

0.97

0.87

2.4

2.3

12.94

13.79

nmol/l

7.61

2761

18266

(3043649) Fibrin monomer [Presence] in Platelet poor plasma by Hemagglutination

1.72

0.87

1.0

1.2

—

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

1425

8612

1.04

0.86

1.1

1.0

—

(3017937) Magnesium [Moles/time] in 24 hour Urine

1.63

0.86

1.1

1.3

—

(36306063) Golimumab Ab [Mass/volume] in Serum or Plasma by Immunoassay

160

0.67

0.85

1.6

1.7

—

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

297

0.76

0.83

1.5

1.7

—

(3013005) Retinol [Moles/volume] in Serum or Plasma

148

817

1.14

0.83

1.4

1.6

2.03

2.02

umol/l

0.07

136

747

(37021550) Renin [Units/volume] in Plasma --upright

403

1.20

0.82

1.2

1.3

93.57

56.39

mu/l

0.98

284

(3035457) Cefaclor IgE Ab [Units/volume] in Serum

134

1.36

0.80

1.1

1.0

0.03

0.05

u/ml

0.65

134

(3018562) Neutrophils/Leukocytes in Cerebral spinal fluid

134

1.36

0.80

1.4

1.5

38.50

37.69

0.04

(3009992) Blasts/cells in Bone marrow

0.00

0.80

0.0

1.7

—

12.67

—

(3035999) Lactate [Moles/volume] in Cerebral spinal fluid

278

1597

1.10

0.79

1.3

2.23

2.22

mmol/l

0.05

257

1482

(3008799) Glucose [Moles/volume] in Serum or Plasma --30 minutes post dose glucose

104

0.61

0.79

1.4

1.0

7.40

8.81

mmol/l

—

104

(3027401) Testosterone Free/Testosterone.total in Serum or Plasma

104

0.61

0.79

1.1

1.3

1.37

1.43

—

104

(3032352) Blasts [#/volume] in Cerebral spinal fluid

251

0.75

0.78

1.2

1.8

—

(3021387) Prolactin [Units/volume] in Serum or Plasma

631

3746

1.06

0.78

1.8

292.72

282.37

mu/l

0.22

570

3488

(3013336) Amino acids [Identifier] in Serum or Plasma

2.25

0.77

3.6

1.9

—

(40763629) HC gene rearrangements [Presence] in Bone marrow by Molecular genetics method

2.25

0.77

1.0

1.1

—

(3042585) Pyridoxine [Moles/volume] in Serum or Plasma

111

604

1.16

0.77

1.2

1.3

145.58

132.59

nmol/l

0.27

418

(3028717) Thiamine [Mass/volume] in Blood

275

1.24

0.76

1.1

1.2

65.96

63.88

ug/l

0.32

275

(3047007) Chlamydophila sp Ab [Presence] in Serum

413

2420

1.08

0.75

1.3

1.2

—

(3023511) Choriogonadotropin [Units/volume] in Urine

602

0.85

0.74

1.3

—

(46235168) Fasting glucose [Moles/volume] in Blood

227

0.75

0.74

1.9

2.3

8.79

7.00

mmol/l

1.74

(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation

950

5717

1.05

0.73

2.0

1.9

200.87

208.05

pmol/l

1.26

898

5437

(40771922) Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by based on 1.73 sq M

142

1.33

0.73

1.2

1.4

0.73

1.20

ml/s/173m2

1.61

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

505

0.84

0.73

1.5

1.7

0.51

1.44

u/ml

1.72

127

(3006567) Chloride [Moles/time] in 24 hour Urine

1.62

0.72

1.2

1.1

—

(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma

513

3036

1.07

0.72

2.6

554.12

999.20

u/ml

0.34

505

3006

(40758358) Immune stain study

0.62

0.72

1.0

—

(3046682) IgA [Presence] in Skin by Immunofluorescence

1.77

0.71

1.0

—

(3027318) Ethylene glycol [Moles/volume] in Serum or Plasma

1.58

0.71

1.0

1.1

—

mmol/l

—

(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma

296

0.79

0.71

2.0

17.63

18.26

umol/l

0.17

296

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

578

0.85

0.70

1.2

1.1

—

(3001218) Citrate [Mass/time] in 24 hour Urine

1.70

0.69

1.7

1.4

419.57

393.04

mg/24h

—

(3028679) Herpes simplex virus Ab [Presence] in Serum

149

837

1.12

0.68

1.2

1.1

—

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

31780

200808

0.98

0.67

16.8

12.3

28.71

26.51

u/l

17.77

31050

194313

(3020874) Milk IgE Ab [Units/volume] in Serum

116

831

0.88

0.67

1.0

0.82

1.04

u/ml

0.23

264

(21494671) JAK2 gene exon 14 targeted mutation analysis in Bone marrow by Molecular genetics method

1.85

0.67

1.0

1.1

—

(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine

178

1.28

0.66

2.1

2.3

—

(21494815) CD4 cells/Lymphocytes in Specimen

290

1689

1.08

0.65

2.0

2.2

40.42

36.56

3.91

281

1657

(3014444) EGFR gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

207

0.76

0.64

1.0

1.1

—

(43534046) Estradiol (E2) [Moles/volume] in Serum or Plasma by High sensitivity method

135

1.31

0.62

1.6

1.2

0.15

0.19

nmol/l

0.35

(3051596) Benzodiazepines [Presence] in Serum or Plasma by Screen method

0.00

0.62

0.0

1.0

—

(3036071) Salmonella sp Ab [Titer] in Serum

510

1.15

0.62

1.1

—

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

463

1.16

0.62

1.1

1.2

—

(3018910) Alkaline phosphatase.bone [Mass/volume] in Serum or Plasma

0.00

0.62

0.0

1.1

—

30.35

—

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

138

970

0.90

0.61

1.1

1.2

—

(3020393) Adenovirus Ag [Presence] in Stool

175

1.26

0.60

1.1

—

(3015694) Chlamydophila pneumoniae IgG Ab [Titer] in Cerebral spinal fluid

0.00

0.60

0.0

1.1

—

(3017074) Chlamydophila pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

0.00

0.60

0.0

1.1

—

(36304315) Certolizumab Ab [Units/volume] in Serum or Plasma by Immunoassay

0.00

0.60

0.0

1.3

—

598.67

—

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

745

4487

1.05

0.60

1.3

1.4

16.72

32.86

e6/l

1.96

582

3265

(40763476) Honey bee phospholipase A2 recombinant (rApi m) 1 IgE Ab [Units/volume] in Serum

0.60

1.1

0.01

1.12

u/ml

—

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

1405

8580

1.03

0.57

3.0

3.8

2656.87

1435.94

u/ml

0.28

1185

7457

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

313

2110

0.93

0.56

1.1

4.25

3.56

eliau/ml

0.23

106

903

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

751

4535

1.04

0.55

1.3

1.5

1233.98

1797.56

e6/l

0.45

628

3513

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

584

0.87

0.55

1.1

1.3

—

(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid

289

1951

0.93

0.54

1.1

58.20

68.58

au/ml

—

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

455

0.86

0.54

1.2

—

(3013945) Hepatitis B virus e Ab [Presence] in Serum

105

1.32

0.54

1.5

1.7

—

(3041184) Isoniazid [Presence] in Urine

1.58

0.54

3.2

2.5

—

(40763590) HLA-DQ beta [Type]

0.68

0.53

1.0

—

(3013862) HLA-DP [Type]

0.65

0.53

1.0

—

(46236302) HLA-C [Type] by High resolution typing

0.65

0.53

1.0

—

(40760410) HLA-B [Type] by High resolution

0.65

0.53

1.0

—

(40760409) HLA-A [Type] by High resolution

0.65

0.53

1.0

—

(4133840) Spirometry

512

1.13

0.53

1.1

1.3

—

(40757578) FLT3 gene targeted mutation analysis in Bone marrow by Molecular genetics method

1.42

0.52

1.1

1.0

—

(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum

459

2744

1.06

0.52

1.1

19.04

15.14

au/ml

0.51

624

(3032868) Hemoglobin electrophoresis panel in Blood

157

0.76

0.50

1.6

1.4

—

(3025577) Chromium [Mass/volume] in Blood

224

1310

1.08

0.50

2.2

2.97

2.35

ug/l

0.75

184

1095

(3037377) Propoxyphene + Norpropoxyphene [Presence] in Urine by Confirmatory method

1.58

0.50

1.0

1.2

—

(3012920) Ethanol [Mass/volume] in Serum or Plasma

1.52

0.48

1.3

2.17

1.95

g/l

—

(3012989) Citrate [Moles/time] in 24 hour Urine

1.52

0.48

1.3

1.4

1.70

2.18

mmol/24h

—

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

831

5050

1.04

0.48

2.7

3.7

1312.89

766.90

u/ml

0.32

753

4570

(3009461) 5-Hydroxyindoleacetate [Moles/time] in 24 hour Urine

1.50

0.47

1.0

1.3

34.08

31.14

umol/24h

—

(4027681) Cerebrospinal fluid IgG ratio and IgG index

162

939

1.09

0.46

1.3

0.50

0.65

ratio

1.36

530

(3017461) Flecainide [Moles/volume] in Serum or Plasma

103

1.29

0.45

1.6

1.5

0.57

0.78

umol/l

1.48

(21494429) FMR1 gene CGG repeat analysis in Blood or Tissue by Molecular genetics method

1.44

0.44

1.1

1.0

—

(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose

160

1.22

0.44

1.1

6.32

6.39

mmol/l

0.21

160

(3047166) Epithelial cells [#/area] in Urine sediment by Automated count

253

1.17

0.44

2.3

2.7

0.60

0.55

u/field

0.11

253

(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid

143

1.23

0.44

1.1

1.0

—

(3008640) Bordetella pertussis IgG Ab [Titer] in Serum

1.66

0.44

1.2

1.0

3821.80

3050.05

titre

—

(3027874) Urate [Moles/volume] in Urine

1.32

0.44

1.1

1.56

1.94

mmol/l

0.63

(3013762) Body weight Measured

0.64

0.43

1.2

—

(40761516) BRAF gene p.Val600Glu [Presence] in Tissue by Molecular genetics method

139

0.77

0.43

1.0

—

(3029612) Listeria sp Ab [Titer] in Serum

0.00

0.42

0.0

1.1

—

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

178

1208

0.93

0.42

1.1

—

(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain

104

1.27

0.42

1.0

1.2

—

(3022229) Phosphate [Moles/volume] in Urine

1.33

0.42

1.0

1.1

12.79

17.27

mmol/l

0.77

(3015822) Parvovirus B19 DNA [Presence] in Serum by NAA with probe detection

1.36

0.42

1.1

—

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

516

1.11

0.42

1.1

—

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

871

5318

1.03

0.41

1.3

—

(3013293) Extractable nuclear Ab [Presence] in Serum

0.00

0.41

0.0

1.0

—

(36304617) Golimumab [Mass/volume] in Serum or Plasma by Immunoassay

186

0.81

0.41

1.6

1.8

1.75

1.64

mg/l

0.14

151

(3017115) Methotrexate [Moles/volume] in Serum or Plasma

288

0.85

0.40

8.5

7.6

0.44

0.32

umol/l

0.92

260

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

127

870

0.92

0.39

1.4

—

(3042934) Triiodothyronine (T3) Ab [Presence] in Serum

1.43

0.39

1.0

1.1

—

(44806420) Estimation of glomerular filtration rate

316

1891

1.05

0.39

2.8

2.6

—

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

280

0.86

0.39

1.4

1.5

—

(3027231) Wheat IgE Ab [Units/volume] in Serum

280

0.86

0.39

1.1

1.0

0.29

1.79

u/ml

0.93

235

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

316

1.14

0.38

1.3

2.3

2.35

143.90

pmol/l

0.53

100

(3045519) Venlafaxine [Moles/volume] in Serum or Plasma

0.74

0.38

1.5

1.6

377.24

521.67

nmol/l

0.77

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

158

1071

0.93

0.38

1.2

1.1

22.41

22.64

u/ml

0.02

401

(3027570) Oxalate [Moles/time] in 24 hour Urine

123

1.23

0.38

1.8

1.3

324.88

342.47

umol/24h

0.16

123

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

142

829

1.08

0.37

2.0

2.1

—

(3019539) Treponema pallidum Ab [Titer] in Serum by Hemagglutination

348

2092

1.05

0.37

1.9

2.0

501.82

3996.61

titre

2.43

118

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

142

830

1.08

0.36

2.0

2.1

—

(3018840) Calcitonin [Moles/volume] in Serum or Plasma

141

1.21

0.36

2.7

3.3

18.12

84.72

pmol/l

—

(3026470) Cobalt [Mass/volume] in Blood

229

1362

1.06

0.36

2.2

2.3

5.14

3.51

ug/l

1.12

213

1257

(3033086) Enterovirus Ab [Titer] in Serum

1.35

0.36

1.1

1.0

—

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

378

1.12

0.35

2.0

1.9

—

(3008898) HLA-B27 [Presence]

800

5193

0.97

0.35

1.0

1.1

—

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

210

1248

1.06

0.35

1.3

1.4

—

(40771901) t(9;22)(q34.1;q11)(ABL1,BCR) b2a2+b3a2 fusion transcript/control transcript (International Scale) [# Ratio] in Blood or Tissue by Molecular genetics method

1.25

0.34

12.9

7.7

—

(3000208) Alpha tocopherol [Moles/volume] in Serum or Plasma

149

876

1.07

0.34

1.4

1.5

29.71

29.36

umol/l

0.13

139

823

(3005411) Squamous cell carcinoma Ag [Mass/volume] in Serum or Plasma

376

0.89

0.34

2.1

1.8

1.89

2.53

ug/l

1.26

232

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

143

840

1.07

0.33

2.0

2.1

—

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

302

0.88

0.33

1.0

1.1

25.58

35.74

iu/ml

0.97

302

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

525

1.09

0.33

1.1

—

(40761872) Peanut recombinant (rAra h) 2 IgE Ab [Units/volume] in Serum

174

0.83

0.33

1.1

0.07

0.67

u/ml

0.60

117

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

749

4587

1.03

0.33

1.2

1.3

4.12

3.77

mmol/l

9.44

703

4349

(3020951) Lymphocytes/Leukocytes in Cerebral spinal fluid

261

1.14

0.33

1.3

1.4

44.20

54.14

0.79

120

(3013803) Aspergillus fumigatus IgG Ab [Mass/volume] in Serum

309

1.12

0.32

1.1

1.3

38.19

43.40

mg/l

0.32

268

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

3811

24307

0.99

0.32

3.5

4.6

20.74

29.49

ug/l

0.82

3128

20055

(3002719) Hemoglobin [Mass/volume] in Urine

1.38

0.32

1.1

1.2

—

(3051659) 25-hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

146

0.82

0.32

1.1

14.43

19.05

nmol/l

—

(43533860) Galactose-alpha-1,3-galactose (Alpha-Gal) IgE Ab [Units/volume] in Serum

200

0.85

0.31

1.2

1.0

0.01

0.43

u/ml

1.16

130

(42529528) Centromere protein B Ab [Units/volume] in Serum by Line blot

370

1.11

0.31

1.2

1.1

—

(3051387) C reactive protein [Mass/volume] in Capillary blood

678

4153

1.03

0.30

4.4

3.3

25.44

28.18

mg/l

1.25

494

2841

(40763480) Human metapneumovirus Ag [Presence] in Specimen

0.77

0.30

1.0

1.6

—

(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid

162

1.17

0.30

1.1

—

(3033888) Pepsinogen I [Mass/volume] in Serum or Plasma

239

1.13

0.30

1.1

1.0

102.61

84.21

ug/l

1.19

172

(40768441) Liver Pathology biopsy report

264

1589

1.05

0.29

1.4

1.3

—

(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma

139

1.18

0.29

1.9

2.1

—

(42529527) Centromere protein A Ab [Units/volume] in Serum by Line blot

222

1.14

0.29

1.1

1.0

—

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

384

1.10

0.29

2.0

1.9

—

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

212

1270

1.05

0.29

1.7

1.8

380.07

320.69

mu/l

0.63

169

1000

(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid

169

1.16

0.28

1.1

—

(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma

1160

7166

1.02

0.28

1.9

39.58

41.60

nmol/l

2.59

1128

6999

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

217

1.13

0.28

1.1

—

(3008092) Baker's yeast IgG Ab [Units/volume] in Serum

1.24

0.27

1.0

33.00

23.40

u/ml

—

(3004593) Baker's yeast IgA Ab [Units/volume] in Serum

1.24

0.27

1.0

49.00

24.88

u/ml

—

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

840

5173

1.02

0.27

1.3

579.73

580.58

mg/l

0.01

796

4944

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

7527

47123

1.01

0.27

3.0

3.2

0.73

0.78

ug/l

2.01

5033

30213

(43055514) Macroprolactin [Presence] in Serum or Plasma

218

1.13

0.26

1.5

1.4

—

(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma

196

0.87

0.26

1.2

1.1

—

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

334

2032

1.04

0.25

1.3

—

(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

268

0.89

0.24

1.3

1.1

—

(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood

224

1354

1.04

0.23

2.1

2.6

0.64

0.66

e9/l

0.15

204

1295

(3004268) Protein electrophoresis panel - Cerebral spinal fluid

1.31

0.23

1.4

1.2

—

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

143

950

0.95

0.23

1.1

1.17

u/l

0.01

443

(3000060) B lymphocytes [#/volume] in Blood

439

1.08

0.22

1.6

2.0

0.45

1.26

e9/l

0.56

204

(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

266

0.90

0.22

1.0

—

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

525

1.07

0.22

1.0

1.1

—

(3023006) Beef IgE Ab [Units/volume] in Serum

0.00

0.22

0.0

1.0

—

0.86

—

(3011829) Common Millet IgE Ab [Units/volume] in Serum

0.00

0.22

0.0

1.0

—

0.06

—

(3009677) Dengue virus Ab [Presence] in Serum

1.24

0.22

1.1

—

(3020047) Haemophilus influenzae B Ab [Mass/volume] in Serum

0.00

0.22

0.0

1.4

—

(3026868) Penicillium brevicompactum IgE Ab [Units/volume] in Serum

0.00

0.22

0.0

1.3

—

(3029889) Paecilomyces variottii IgE Ab [Units/volume] in Serum

0.00

0.22

0.0

1.3

—

(3014257) Rhodotorula spp IgE Ab [Units/volume] in Serum

0.00

0.22

0.0

1.3

—

(3035153) Lemon IgE Ab [Units/volume] in Serum

0.00

0.22

0.0

1.1

—

(3041672) Baker's yeast Ab [Presence] in Serum

1.21

0.21

1.0

—

(3014064) Pregnancy associated plasma protein A [Multiple of the median] in Serum or Plasma

0.00

0.21

0.0

1.0

—

1.25

—

(3021162) Amylase [Enzymatic activity/volume] in Specimen

428

0.93

0.20

3.0

2.9

678.06

1732.07

u/l

1.08

382

(3027300) Silver Birch IgE Ab [Units/volume] in Serum

408

0.93

0.20

1.0

6.34

7.45

u/ml

0.28

255

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

110

732

0.95

0.20

1.1

—

(3003633) Ovomucoid IgE Ab [Units/volume] in Serum

1.24

0.20

1.2

1.0

2.24

1.25

u/ml

0.21

(3025443) Phadiatop IgE Ab [Units/volume] in Serum

118

781

0.95

0.18

1.0

1.1

4.59

5.94

u/ml

0.28

110

(3026029) Penicillin V IgE Ab [Units/volume] in Serum

1.18

0.18

1.3

1.0

0.32

0.17

u/ml

—

(40762814) Titanium [Mass/volume] in Blood

399

0.93

0.18

2.5

2.6

3.08

3.61

ug/l

0.70

150

(3024316) Viscosity of Plasma

110

1.15

0.18

1.6

2.3

1.52

1.83

mpas

1.53

(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma

1.16

0.18

1.0

1.1

—

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

207

1.10

0.17

1.1

—

(3031067) HIV 1 p24 Ag [Mass/volume] in Serum or Plasma by Immunoassay

1.20

0.17

1.0

—

(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum

199

1212

1.04

0.17

1.0

1.1

10.01

9.22

iu/ml

0.17

292

(3033942) Copper [Moles/time] in 24 hour Urine

1.19

0.17

1.1

0.49

0.68

umol/24h

—

(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum

149

0.89

0.16

1.1

82.29

95.79

titre

0.49

149

(3020650) Glucose [Presence] in Urine

648

0.95

0.16

1.6

0.06

0.04

estimate

0.19

648

(3019225) pH of Specimen

3314

21022

0.99

0.14

5.9

4.1

7.35

7.36

1.56

2583

14658

(3025018) Bordetella pertussis Ab [Titer] in Serum

182

1113

1.03

0.13

1.2

—

(3035509) Tobramycin [Mass/volume] in Serum or Plasma

210

1.08

0.13

4.6

2.7

1.29

0.98

mg/l

1.20

148

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

172

1051

1.03

0.13

1.1

—

(3001556) Androgen free Index in Serum or Plasma

0.83

0.13

1.3

1.4

—

(3031659) Enterovirus Ab [Titer] in Cerebral spinal fluid

0.81

0.13

1.1

—

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

494

1.05

0.13

1.1

1.2

—

(3007625) Streptococcus pneumoniae Ag [Presence] in Specimen

0.85

0.12

1.0

1.7

—

(3022475) Manganese [Moles/volume] in Blood

107

0.88

0.12

1.4

1.3

0.16

umol/l

0.13

107

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

248

1.07

0.12

1.1

1.3

—

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

248

1.07

0.12

1.1

1.3

—

(3003577) Lead [Moles/volume] in Blood

152

0.91

0.11

1.4

1.6

0.30

0.20

umol/l

—

(40761873) Peanut recombinant (rAra h) 1 IgE Ab [Units/volume] in Serum

106

0.89

0.11

1.0

0.04

0.18

u/ml

—

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

274

1760

0.98

0.10

1.0

751.03

749.56

ng/l

0.02

188

1238

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

281

1.05

0.10

1.2

1.1

—

(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid

273

1752

0.98

0.09

1.0

290.19

348.94

ng/l

1.64

191

1282

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

279

0.95

0.09

1.2

1.1

—

(3041449) Collagen crosslinked C-telopeptide [Mass/volume] in Serum or Plasma

100

611

1.03

0.09

1.6

0.47

0.36

ug/l

1.87

419

(3035401) Herpes virus 6 DNA [Presence] in Specimen by NAA with probe detection

1.12

0.09

1.3

—

(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay

275

1763

0.98

0.09

1.0

38.48

42.08

ng/l

0.65

191

1273

(3034099) Cytomegalovirus Ab [Titer] in Cerebral spinal fluid

1.08

0.09

1.2

1.1

—

(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis

182

0.94

0.09

4.8

5.4

—

(3010937) Rubella virus Ab [Presence] in Serum

1.13

0.08

1.1

1.0

—

(3041293) ARIPiprazole [Mass/volume] in Serum or Plasma

0.79

0.08

1.4

2.0

172.74

261.91

ug/l

—

(40761871) Peanut recombinant (rAra h) 3 IgE Ab [Units/volume] in Serum

104

0.91

0.08

1.0

0.05

0.02

u/ml

—

(4198724) Urine methamphetamine measurement

527

0.97

0.08

1.7

2.0

—

(3025886) Oxalate [Mass/time] in 24 hour Urine

1.03

0.08

1.0

1.1

31.10

35.43

mg/24h

—

(3007368) IgG [Mass/volume] in Cerebral spinal fluid

209

1341

0.98

0.08

1.2

44.40

48.71

mg/l

0.53

168

1139

(3042299) inFLIXimab [Mass/volume] in Serum or Plasma

514

1.03

0.07

3.2

7.80

8.17

mg/l

0.20

420

(3018688) Ampicillin IgE Ab [Units/volume] in Serum

0.83

0.07

1.1

0.04

u/ml

—

(21493619) Chromosome 12 trisomy and chromosome region 11q22.3 and 13q14 and 17p13.1 deletion in Blood or Tissue by FISH

116

0.92

0.07

1.3

1.2

—

(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method

193

0.95

0.07

1.2

1.0

—

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

295

0.96

0.06

1.6

1.5

57.16

56.66

ug/l

0.04

295

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

248

1.04

0.06

1.1

1.3

—

(4212803) Bone marrow aspirate examination

199

1.05

0.05

1.0

1.1

—

(3024474) Albumin [Mass/volume] in Cerebral spinal fluid

202

1289

0.99

0.05

1.1

305.62

317.39

mg/l

0.24

169

1150

(3017509) Phencyclidine [Presence] in Urine

127

0.94

0.04

1.2

1.4

—

(3036048) Francisella tularensis Ab [Titer] in Serum

475

1.02

0.04

1.2

680.00

664.62

titre

—

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

588

1.02

0.04

2.4

3.3

2.00

1.74

ratio

0.49

532

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

244

1.03

0.04

1.1

—

(3018001) Oat IgE Ab [Units/volume] in Serum

101

0.94

0.04

1.1

1.0

0.14

0.31

u/ml

—

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

400

0.98

0.04

1.8

1.7

—

(3012494) Peanut IgE Ab [Units/volume] in Serum

330

0.97

0.04

1.1

0.87

0.85

u/ml

0.01

172

(40760435) Tropomyosin IgE Ab [Units/volume] in Serum

126

1.05

0.03

1.1

1.0

0.96

0.40

u/ml

0.43

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

185

1178

0.99

0.03

1.1

—

(44806071) Cardiolipin IgM antibody measurement

226

1.03

0.03

1.2

1.1

—

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

332

2107

0.99

0.03

1.4

1.5

—

(1175556) inFLIXimab Ab [Units/volume] in Serum by Immunoassay

462

0.98

0.03

2.7

2.4

204.98

166.25

au/ml

0.26

(3051101) Glucose [Moles/volume] in Cord blood

354

0.98

0.03

6.3

6.0

9.03

8.16

mmol/l

1.24

354

(40760849) Centromere Ab [Presence] in Serum by Immunoblot

0.93

0.02

1.2

1.1

—

(40758292) HTLV I+II Ab panel - Serum

410

0.98

0.02

1.2

1.4

—

(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid

1.05

0.02

1.0

—

(723473) SARS-CoV-2 (COVID-19) IgA Ab [Presence] in Serum or Plasma by Immunoassay

1.07

0.02

1.1

1.2

—

(40767665) Peanut recombinant (rAra h) 9 IgE Ab [Units/volume] in Serum

1.00

0.00

1.0

0.61

0.86

u/ml

—

(37020271) Myelin oligodendrocyte glycoprotein Ab [Titer] in Serum by Cell binding immunofluorescent assay

1.01

0.00

1.3

1.0

—

(3004446) Plasmodium sp identified in Blood by Light microscopy

160

0.98

0.00

2.6

—

(3005011) Chlamydia sp Ab [Titer] in Serum

215

1.00

0.00

1.8

1.7

—

(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

143

1.01

0.00

1.2

1.1

—

(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method

173

1.02

0.00

1.1

—

(40765096) Chromosome analysis panel by Banding

110

694

1.00

0.00

1.1

1.2

—

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

316

1.00

0.00

1.2

1.1

—

(3029396) Erythrocyte agglutination [Presence] in Blood

1.02

0.00

1.4

1.9

—

(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid

104

1.03

0.00

1.0

—

(3018291) Platelet Ab [Presence] in Serum

0.98

0.00

1.0

1.1

—

(3007919) Fasciola sp Ab [Titer] in Serum

0.85

0.00

1.2

1.0

—

(3028050) Streptolysin O Ab [Titer] in Serum

0.00

-0.00

0.0

1.0

—

147.60

—

(3032492) JC virus DNA [#/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection

0.94

-0.00

1.1

—

(3045759) Histamine [Moles/volume] in Serum or Plasma

0.00

-0.00

0.0

2.0

—

(3006598) pH of Arterial cord blood

0.00

-0.00

0.0

1.2

—

(3009220) Epithelial cells.squamous [#/volume] in Urine sediment

0.00

-0.00

0.0

1.2

—

0.86

—

(4038314) Semen analysis, post vasectomy

0.88

-0.00

1.0

1.2

—

(3015531) Creatine kinase.macromolecular [Enzymatic activity/volume] in Serum or Plasma

0.00

-0.00

0.0

1.2

—

0.00

—

(3006392) Corynebacterium diphtheriae [Presence] in Specimen by Organism specific culture

0.00

-0.00

0.0

1.0

—

(3017501) Neutrophils [#/volume] in Blood by Manual count

0.00

-0.00

0.0

1.3

—

(3020071) Venlafaxine [Mass/volume] in Serum or Plasma

0.00

-0.00

0.0

1.0

—

359.60

—

Mortality – FinRegistry

↥

Association

Association between endpoint I9_CORATHER and mortality.

Females

Parameter	HR [95% CI]	p-value
I9_CORATHER	1.931 [1.79, 2.09]	< 0.001
Birth year	0.987 [0.98, 1.0]	0.001

During the follow-up period (1.1.1998 — 31.12.2019), 89079 out of 166934 females with I9_CORATHER died.

Males

Parameter	HR [95% CI]	p-value
I9_CORATHER	1.649 [1.53, 1.78]	< 0.001
Birth year	0.987 [0.98, 0.99]	0.001

During the follow-up period (1.1.1998 — 31.12.2019), 96810 out of 219429 males with I9_CORATHER died.

Mortality risk

Mortality risk for people of age

years, who have I9_CORATHER.

N-year risk	Females	Males
1	0.111%	0.214%
5	0.798%	1.488%
10	2.045%	3.61%
15	3.793%	7.058%
20	6.181%	11.9%

Relationships between endpoints

↥

Index endpoint: I9_CORATHER – Coronary atherosclerosis

GWS hits: 147

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

rg [CI]

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Coronary atherosclerosis

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS

Matched cohort

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints